EurekaMag PDF full texts Chapter 35,013

Gobin, S.J.P.; Biesta, P.; D.S.eenwinkel, J.E.M.; Datema, G.; Van Den Elsen, P.J. 2002: HLA-G transactivation by cAMP-response element-binding protein An alternative transactivation pathway to the conserved major histocompatibility complex class I regulatory routes. Journal of Biological Chemistry 277(42): 39525-39531

Backstrom, G.M. 2003: HLA-G typing with SnaPshotTM DDNTP primer extension technique. Genes and Immunity 4(Suppl 1): S64

Rieger, L.; Kaemmerer, U.; Dietl, J. 2000: HLA-G-positive and -negative chorioncarcinoma cells modulate the production of Th1/Th2 cytokines of human decidua cells. Human Reproduction 15(Abstract Book 1): 177-178

Carreiras, M.; Visconti, V.; Layrisse, Z. 2000: HLA-G/A haplotypes in pre-eclampsia and recurrent spontaneous abortions. Human Immunology 61(Suppl 2): S134

Rouas Freiss, N.; Ritean, B.; Menier, C.; Carosella, E.D.lphino 2001: HLA-G1 co-expression boosts the HLA class I mediated NK lysis inhibition Involvement of ILT-2 and KIR2DL4 inhibitory receptors. FASEB Journal 15(4): A350

Stackelberg, A.V.; Koch, T.; Ebell, W.; Klingebiel, T.; Peters, C.; Fuhrer, M.; Henze, G. 2002: HLA-Matched Family Donor Stem-Cell Transplantation in Childhood Relapsed ALL; the ALL-REZ BFM Experience. Blood 100(11): Abstract No. 3369

Boediardja, S.A.; Cornain, S.; Zain, M.S.; Tjarta, A.; Roostini, E.S.; Budimulja, U.; Dijuanda, A.; Hartati, M. 2002: HLA-antigens and immunopathological analysis in Prurigo Hebra. Tissue Antigens 59(2 Suppl): 122

Clark, R.E.; Dodi, I.A.; Lill, J.R.; Hill, S.C.; Rojas, J.; Wang, L.; Christmas, S.E.; Bonner, P.L.R.; Creaser, C.S.; Rees, R.C.; Madrigal, J.A. 2001: HLA-associated peptides derived from BCR-ABL are expressed on the CML cell surface. British Journal of Haematology 113(Suppl 1): 4

Spellman, S.; Cullen, R.; Maiers, M.; Fernandez Vina, M.; Williams, T.M.; Baxter Lowe, L.; Hurley, C.K. 2003: HLA-class I ambiguity resolution in the National Marrow Donor Program Donor/Recipient Pair Project When is enough enough?. Human Immunology 64(Suppl 1): S5

Heinemann, F.; Ferencik, S.; Grosse Wilde, H. 2003: HLA-class I and class II typing using reverse SSO methodology in combination with fluorescent microspheres and flow analyzer. Genes and Immunity 4(Suppl 1): S64

Poles, A.; Brookes, P.; Sergeant, R.; Mccluskey, M.; Davey, N. 2003: HLA-class I high resolution typing by RSCA. Genes and Immunity 4(Suppl 1): S58

Compaso, S.; Giovannardi, S.; Colombo, G.; Rossetti, C.; Scorza, R. 1999: HLA-class I molecules differently influence intracellular calcium signalling. Human Immunology 60(Suppl 1): S32

Silva, E.M.B.T.; Fernandes, M.I.M.; Galvao, L.C.; Sawamura, R.; Donadi, E.A. 2000: HLA-class II alleles in Brazilian Caucasoid patients with celiac disease. JPGN 31(Suppl 2): S146

Constantinidou, N.; Polychronopoulou, S.; Spanou, K.; Panagiotou, J.P.; Chaidaroglou, A.; Markantonatos, P.; Kanariou, M.; Haidas, S. 2001: HLA-class II alleles in childhood acute lymphoblastic leukemia. European Journal of Immunogenetics 28(2): 317

Bedane, C.; Drouet, M.; Boulinguez, S.; Boulanger, M.D.; Vaillant, L.; Bonnetblanc, J.M. 2000: HLA-class II alleles influence anti-BPAG1 and anti-BPAG2 autoantibody response in bullous pemphigoid in French caucasians. Journal of Investigative Dermatology 115(3): 578

Drouet, M.; Boulanger, M.D.; Delpuguet Bertin, N.; Vaillant, L.; Chauchaix, S.; Bonnetblanc, J.M.; Bedane, C. 2000: HLA-class II alleles influence anti-BPAG1 and anti-BPAG2 autoantibody responses in bullous pemphigoid in French caucasians. Human Immunology 61(Suppl 1): S70

Marchini, M.; Prampolini, L.; Antonioli, R.; Fredella, C.; Scorza, R. 2002: HLA-class II antigens and celiac disease A study in 22 Italian patients and 11 families. Tissue Antigens 59(2 Suppl): 137-138

Brasanac, D.; Markovic Lipkovski, J.; Basta Jovanovic, G.; Mueller, G.A.; Mueller, C.A. 1999: HLA-class II antigens expression in renal cell carcinoma. Virchows Archiv 435(3): 362

Shanmugalakshmi, S.; Pitchappan, R.M. 2002: HLA-class II high risk alleles influence the TCRVB usage in pulmonary tuberculosis patients from south India. Tissue Antigens 59(2 Suppl): 139

Renquin, J.; Sanchez Mazas, A.; Halle, L.; Rivalland, S.; Jeager, G.; Mbayo, K.; Bianchi, F.; Kaplan, C. 2001: HLA-class II polymorphism in Aka Pygmies and Bantu Congolese. European Journal of Immunogenetics 28(2): 276

Neumann, D.; Freyer, C.; Westphal, B.; Jenisch, S.; Zierhut, M.; Noelle, B. 2000: HLA-class II-typing in intermediate uveitis. IOVS Investigative Ophthalmology and Visual Science 41(4): S369

Morozova, N.; Belousova, E.; Zlatkina, A.; Serova, L. 2000: HLA-dependent and HLA-independent forms of ulcerative colitis in Russia. Digestive and Liver Disease 32(Suppl 1): A27

Alexeev, L.P.; Dedov, I.I.; Boldyreva, M.N.; Zilov, A.V.; Khaitov, R.M. 2003: HLA-genes Markers of insulin-dependent diabetes mellitus Ethnic aspects. Immunologiya 24(5): 308-311

Boldyreva, M.N.; Trofimov, D.Y.; Jankevich, T.E.; Bogatova, O.V.; Gouskova, I.A.; Philippova, E.V.; Sergeev, I.V.; Alexeev, L.P. 2003: HLA-genes diversity among 5 Russian groups from different regions of Russian European part. Genes and Immunity 4(Suppl 1): S29

Kuznetsova, N.; Yu, A.; Afanasyeva, I. 2001: HLA-haplotypes in patients with porphyria cutanea tarda and their relatives. Journal of Investigative Dermatology 117(2): 551

D'souza, Marion; Valluri, Vijaya Lakshmi; Mustafa, Maha; Santhosh, Anitha; El Hag, Mohd; Gumama, Olan; Abdel Wareth, Laila Osama 2001: HLA-identical related donor frequency in bone marrow transplantation A population based study. Human Immunology 62(Suppl 1): S111

Chalandon, Y.; Roosnek, E.; Waelchli, L.; Helg, C.; Chapuis, B. 2003: HLA-identical sibling peripheral blood stem cell transplantation for hematological malignancies Limited GVHD and a 69% 4-years DFS after partial in vitro T-cell depletion with CAMPATH-1H in combination with DLI for CML molecular relapses. Blood 102(11): 464a

Karell, K.; Klinger, N.; Holopainen, P.; Levo, A.; Partanen, J. 2000: HLA-linked microsatellite markers in a founder population. Scandinavian Journal of Immunology 52(3): 318

Cullup, H.; Wang, X.N.; Dickinson, A.M. 2003: HLA-matching influences the production of the IL-1 family of cytokines in an alloimmune response. Genes and Immunity 4(Suppl 1): S47

Lambert, N.C.; Erickson, T.D.; Tylee, T.S.; Pang, J.M.; Furst, D.; Nelson, J.L. 2002: HLA-relationships, microchimerism and scleroderma A study in three generations. Tissue Antigens 59(2 Suppl): 43

Vitiello, M.A.; Chesnut, R.W. 2001: HLA-restricted hepatitis B virus CTL epitopes. Official Gazette of the United States Patent and Trademark Office Patents 1252(4)

Tarsitani, C.; Etessami, S.; Terasaki, P.I. 2001: HLA-specific magnetic beads for separation of chimeric cells. Human Immunology 62(Suppl 1): S140

Reimer, P.; Wilhelm, M.; Goebeler, M.E.; Goldmann, S.; Mueller, C.; Fischbach, W. 2002: HLA-status in MALT lymphoma. Gastroenterology 122(4 Suppl 1): A-175

Dettling, M.; Cascorbi, I.; Roots, I.; Muller Oerlinghausen, B. 2000: HLA-subtyping in German Caucasians with clozapine induced agranulocytosis. American Journal of Medical Genetics 96(4): 539

Hauck, E.W.; Warten, U.; Hackstein, H.; Schroeder Printzen, I.; Bein, G.; Weidner, W. 2000: HLA-system screening in Peyronies disease. Journal of Urology 163(4 Suppl): 168

Kurilovich, S.A.; Shlykova, L.G.; Konenkov, V.I. 2000: HLA-type in Hp-positive patients with duodenal ulcer in Caucasian population of western Siberia. Gut 47(Suppl 1): A79

Fischer, G.F.; Kriks, D.; Fae, I.; Volc Platzer, B.; Jaeger, W.; Platzer, W.; Mayr, W.R.; Mann, D. 1999: HLA-typing of the Tyrolean Iceman. Human Immunology 60(Suppl 1): S28

Duquesnoy, R.J.; Marrari, M. 1999: HLAMatchmaker A molecularly based donor selection strategy for highly allosensitized patients. Human Immunology 60(Suppl 2): S24

Askar, M.Z.; Duquesnoy, R.J. 2003: HLAMatchmaker-based determination of HLA-DR and HLA-DQ compatibility at the structural level. Human Immunology 64(Suppl 1): S36

Nambiar, A.; Adams, S.; Reid, J.; Oblitas, J.; Leitman, S.; Duquesnoy, R.; Stroncek, D.; Marincola, F. 2003: HLAMatchmaker-driven analysis of response to HLA matched platelet transfusions. Human Immunology 64(Suppl 1): S77

De Canck, I.; Thienpont, N.; Vande Casteele, N.; Verhelst, An; Rombout, A.; De Vreese, K.; Norton, J.; Verpooten, G. 2002: HLA_A allele group and null allele typing using the LiPA HLA-A update kit. Tissue Antigens 59(2 Suppl): 144

Barnes, M.R. 2000: HLDAT86 polynucleotides. Official Gazette of the United States Patent and Trademark Office Patents 1241(4)

Smirnova, E.V.; Evtodienko, A.Y.; Rakitina, T.V.; Kostanyan, I.A.; Lipkin, V.M. 2000: HLDF mRNA derives from rpS21 gene during human promyelocytic cell line HL-60 differentiation. Biochemical Society Transactions 28(5): A238

Kim, S.; Mclaughlin, S.K. 1999: HLH transcription factors in taste receptor cells. Society for Neuroscience Abstracts 25(1-2): 2269

Merello, Elisa; Moroni, A.; De Marco, P.; Lindsay, S.; Strachan, T.; Cama, A.; Capra, V. 2000: HLXB9 is mutated in Caudal Regression Syndrome. European Journal of Human Genetics 8(Suppl 1): 132

Figueiredo, C.; Seltsam, A.; Holtkamp, U.; Blasczyk, R. 2004: HLa silencing by RNAi-mediated transcript targeting. Genes and Immunity 5(Suppl 1): S6

E.B.nayosy, A.; Arusoglu, L.; Morshuis, M.; Kizner, L.; Tenderich, G.; Raulf, J.; Cobaugh, D.; Koerfer, R. 2002: HM II Initial experience with the Heart Mate II axial flow pump. International Journal of Artificial Organs 25(7): 691

Smith, H.O.; Pollard, J.W.; Dorin, M.H.; Griffith, J.K.; Dominguez, C.E.; Stephens, N.D. 1999: HM-CSF production in human endometrial cells in vitro and in vivo The role of cell type on the differential production of growth factors. Gynecologic Oncology 72(3): 504

Ko, Kwang Ho 1999: HM02 and HM03, against human airway mucin. Hybridoma 18(5): 470

Portis, A.J.; Yan, Y.; Pattaras, J.G.; Andreoni, C.; Moore, R.G.; Clayman, R.V. 2000: HM3 versus Lithotron Matched pair analysis of shock wave lithotripsy effectiveness. Journal of Endourology 14(Suppl 1): A23

Nishioka, D.; Wu, R.S.; Rha, S.Y.; Von Hoff, D.D.; Izbicka, E. 1999: HMAF induces chromosome destabilization in developing sea urchin embryos. Proceedings of the American Association for Cancer Research Annual Meeting 40: 3

Brasanac, D.; Boricic, I.; Tatic, S. 2003: HMB-45 and melan-A positive pigmented epidermotropic breast carcinoma metastasis. Virchows Archiv 443(3): 374

Barcus, M.E.; Williams, R.L.; Gainey, T.W.; Lamb, T.; Bach, D.; Kornstein, M.J.; Burks, R.T. 2000: HMB-45 immunoreactivity in uterine mesenchymal tumors. Laboratory Investigation 80(3): 120A

Smolarek, T.A.; Bejarano, P.A.; Heffelfinger, S.; Menon, A.G. 1999: HMB-45 immunoreactivity is present in both uterine leiomyomas and normal myometrium. Modern Pathology 12(1): 125A

Baisden, B.L.; Westra, W.H. 1999: HMB-45 staining of sentinel lymph nodes A sensitive and specific method for the detection of micrometastases in patients with malignant melanoma. Modern Pathology 12(1): 55A

Wang, Q.-h.; Xie, Y.; Fan, H.-h. 2004: HMBA-induced differentiation of myeloid leukemic cell lines is associated with altered G1 cell cycle regulators and related genes. Chinese Medical Journal 117(3): 453-455

Diehl, S.D.; Delgado, E.; Baker, B.W. Jr 2003: HME bypass system. Official Gazette of the United States Patent and Trademark Office Patents 1272(2)

Laronga, C.; Neal, C.; Lee, M.H. 1999: HME1, a 14-3-3 family member, is a regulator of the cell cycle. Proceedings of the American Association for Cancer Research Annual Meeting 40: 215

Grantham, J.A.; Rajamannan, N.M.; Burnett, J.C.Jr 1999: HMG CoA reductase inhibition attenuates vascular endothelin-1 generation in experimental atherosclerosis. Circulation 100(18): 1; 622

Walsh, K. 2004: HMG CoA reductase inhibitors for promoting angiogenesis. Official Gazette of the United States Patent and Trademark Office Patents 1279(2)

Lembertas, A.V.; Ma, J.; Tseng, R.S.; Go, V.L.ang W.; Heber, D. 2001: HMG CoA synthase upregulation in HepG2 cells following exposure to Chinese red yeast rice dietary supplement vs lovastatin. FASEB Journal 15(4): A403

Chen, C.M.; Chou, J.; Wong, D. 1999: HMG co-reductase inhibitor. Official Gazette of the United States Patent and Trademark Office Patents 1223(5)

Roy Chaudhury, P.; Faiyaz, R.; Kant, S.; Kelly, B.; Duncan, H. 2002: HMG coenzyme reductase inhibitors for hemodialysis vascular access dysfunction. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 231A

Sallam, H.N.; Sallam, A.N.; Ezzeldin, F.; Abou Ali, A.A.; Khanfour, A. 1999: HMG versus oral progesterone supplementation in the treatment of early repeated pregnancy loss due to luteal phase insufficiency. Human Reproduction 14(ABSTR BOOK 1): 261

Wang, H.; Wang, H.; Christen, E.; Tracey, K.J.; Trachtman, H. 2001: HMG-1 excretion is increased in children with diarrheal-associated hemolytic uremic syndrome. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 185A

Wang, H.; Yang, H.; Andersson, U.; Zhang, M.; Sama, A.; Tracey, K.J. 1999: HMG-1 induces TNF synthesis in human peripheral blood mononuclear cells. Cytokine 11(11): 968

Wang, H.; Bloom, O.; Zhang, M.; Omrellino, M.; Vishnvbhakat, J.; Che, J.; Borovikova, L.; Frazier, A.; Ivanova, S.; Sama, A.; Tracey, K.J. 1999: HMG-1 is an inducible mediator of lethal endotoxemia. FASEB Journal 13(4 Part 1): A487

Tracey, K.J. 2000: HMG-1 mediates delayed endotoxin lethality. Scandinavian Journal of Immunology 51(Suppl 1): 15

Harris, H.E.; Wang, H.; Palmblad, K.; Aveberger, A.C.; Bloom, O.; Jansson, A.; Kokkola, R.; Zhang, M.; Yang, H.; Tracey, K.J.; Andersson, U. 2001: HMG-1 stimulates proinflammatory cytokine synthesis in human monocytes. Diabetes-Metabolism Research and Reviews 17(Suppl 1): S39

Zhang, C.C.; Krieg, S.; Shapiro, D.J. 1999: HMG-1 stimulates the activity of human estrogen receptor. FASEB Journal 13(7): A1470

Wang, H.; Zhang, M.; Andersson, U.; Yang, H.; Frazier, A.; Pizzi, M.D.; Sama, A.; Tracey, K.J. 2000: HMG-1, a late mediator of endotoxin lethality, stimulates nitric oxide and TNF. FASEB Journal 14(4): A289

Hermann, M.; Ruschitzka, F.; Camici, G.; Shaw, S.; Luscher, T.F. 2003: HMG-COA reductase inhibitor improves endothelial dysfunction in mineralocorticoid hypertension by inhibition of RhoA. American Journal of Hypertension 16(5 Part 2): 24A

Hoelschermann, H.; Hilgendorff, A.; Tillmanns, H.; Haberbosch, W. 2001: HMG-COA-reductase inhibitors suppress transcriptional activation of NF-kB in monocytes. Annals of Hematology 80(Suppl 1): A28

Kothe, H.; Rupp, J.; Dalhoff, K.; Maass, M.; Katus, H. 1999: HMG-Co A reductase inhibitors are modifying the inflammatory response of human macrophages infected by Chlamydia pneumoniae. Journal of the American College of Cardiology 33(2 Suppl A): 260A

Mitsiades, C.S.; Mitsiades, N.; Poulaki, V.; Fanourakis, G.; Richardson, P.G.; Shringapurne, R.; Akiyama, M.; Chauhan, D.; Hideshima, T.; Treon, S.P.; Munshi, N.C. 2002: HMG-CoA Inhibitors Induce Growth Arrest, Apoptosis of Multiple Myeloma and Waldenstroms Macroglobulinemia Cells and Enhance Their Sensitivity to Conventional or Novel Therapies Molecular Profiling of HMG-CoA Inhibition in MM/WM and Framework for Translation to Therapeutic Application. Blood 100(11): Abstract No. 2349

Wagner, C.A.; Li, S.; Friesen, J.A.; Borst, D.W. 2003: HMG-CoA Reductase activity in the fat body of the lubber grasshopper, Romalea microptera. SICB Annual Meeting and Exhibition Final Program and Abstracts : 333

Giannios, J.; Ginopoulos, P. 1999: HMG-CoA inhibitor-lovastatin sensitizes highly aggressive breast carcinoma to PCD induced by vinorelbine, upregulating BAX, p53 and downregulating RhoA-GTPase, bcl-2. European Journal of Cancer 35(Suppl 4): S319

Lankin, V.Z.; Tikhaze, A.K.; Konovalova, G.G.; Kukharchuk, V.V. 2001: HMG-CoA inhibitors induced the LDL oxidation. Journal of Molecular and Cellular Cardiology 33(6): A65

Funghini, S.; Pasquini, E.; Donati, M.A.; Morrone, A.; Zammarchi, E. 2000: HMG-CoA lyase deficiency in an Italian patient is caused by a new nonsense mutation in HMGCL gene. American Journal of Human Genetics 67(4 Suppl 2): 287

Li, S.; Wagner, C.A.; Fei, H.; Friesen, J.A.; Borst, D.W. 2003: HMG-CoA reductase activity in the mandibular organ of the lobster, Homarus americanus. SICB Annual Meeting and Exhibition Final Program and Abstracts : 229-230

Li, S.; Wagner, C.A.; Friesen, J.A.; Borst, D.W. 2001: HMG-CoA reductase and its regulation in the mandibular organ of the lobster, Homarus americanus. American Zoologist 41(6): 1646

Eto, M.; Cosentino, F.; Kozai, T.; Luscher, T.F. 2001: HMG-CoA reductase inhibition by simvastatin prevents thrombin-induced tissue factor expression in human endothelial cells Role of Rho/ROCK pathway. Circulation 104(17): 2; 203-II 204

Shukla, A.K.; Uzui, H.; Doherty, T.M.; Tripathi, P.V.; Asotra, K.; Wilkin, D.J.; Shah, P.K.; Rajavashisth, T.B. 2002: HMG-CoA reductase inhibition downregulates tumor necrosis factor-alpha and oxidized low density lipoprotein-induced endothelial cell expression of macrophage-colony stimulating factor. Circulation 106(19): II302

Weis, M.; Heeschen, C.; Cooke, J.P. 2001: HMG-CoA reductase inhibition has biphasic effects on angiogenesis. Circulation 104(17): 2; 124

Bauersachs, J.; Fraccarollo, D.; Galuppo, P.; Ertl, G.; Christ, M. 2001: HMG-CoA reductase inhibition in rats with heart failure after myocardial infarction Improvement of left ventricular function correlates with reduction in collagen expression. European Heart Journal 22(Abstract Suppl): 140

Mollnau, H.; Meinertz, T.; Hink, U.; Muenzel, T. 2000: HMG-CoA reductase inhibition inhibits vascular NADH oxidase activity, prevents uncoupling of nitric oxide synthase and improves endothelial dysfunction in cholesterol fed rabbits. European Heart Journal 21(Abstract Suppl): 16

Weis, M.; Heeschen, C.; Glassford, A.J.; Tsao, P.S.; Cooke, J.P. 2001: HMG-CoA reductase inhibition interacts with endothelial apoptosis and VEGF signaling under hypoxia. Circulation 104(17): 2; 153-II 154

Mollnau, H.; Hartmann, M.; Matheis, E.; Munzel, T. 1999: HMG-CoA reductase inhibition normalizes endothelial dysfunction by inhibiting NADH oxidase activity and nitric oxide synthase mediated superoxide production in experimental hyperlipidemia. Circulation 100(18): 1; 621

Zeng, L.; Chew, T.L.; Chisholm, R.L.; Kanwar, Y.S.; Rahimi Danesh, F. 2003: HMG-CoA reductase inhibition protects glomerular endothelial cells from VEGF-induced hyperpermeability in diabetic milieu. Journal of the American Society of Nephrology 14(Abstracts Issue): 125A

Dechend, R.; Gieffers, J.; Joerres, A.; Luft, F.C.; Maass, M.; Dietz, R. 2002: HMG-CoA reductase inhibition reduces chlamydia pneumoniae induced macrophage Vascular smooth muscle cell interaction and activation. Circulation 106(19): II187-II188

Liang, K.; Vaziri, N.D. 2003: HMG-CoA reductase inhibition with rosuvastatin improves hyperlipidemia and proteinuria and reverses LDL receptor and HDL receptor deficiencies in nephrotic syndrome. Journal of the American Society of Nephrology 14(Abstracts Issue): 168A

Cioppa, A.; Indolfi, C.; Coppola, C.; Stabile, E.; Pisani, A.; Perrino, C.; Stingone, A.M.; Pascotto, M.; Chiariello, M. 1999: HMG-CoA reductase inhibitor Simvastatin inhibits smooth muscle cell proliferation in vitro and prevents the neointimal formation after stenting. European Heart Journal 20(ABSTR Suppl ): 608

Kliche, S.; Frank, H.; Meyer, N.; Waltenberger, J. 2002: HMG-CoA reductase inhibitor blocks VEGFR-2-mediated endothelial migration. European Heart Journal 23(Abstract Suppl): 420

Yufu, T.; Hirano, K.; Bi, D.; Hirano, M.; Nishimura, J.; Kanaide, H. 2003: HMG-CoA reductase inhibitor down-regulates expression of protease-activated receptor 1 on the plasma membrane and reduces the responsiveness to thrombin in the human coronary artery smooth muscle cells. Circulation 108(17): IV202

Takayama, T.; Wada, A.; Ohnishi, M.; Fujii, M.; Matsumoto, T.; Yamamoto, T.; Dohke, T.; Ishii, C.; Ohno, K.; Tsutamoto, T.; Horie, M. 2003: HMG-CoA reductase inhibitor improves left ventricular diastolic function via modification of NADPH oxidase and NO system in heart failure. Circulation 108(17): IV7-IV8

Nakamura, R.; Egashira, K. 2001: HMG-CoA reductase inhibitor pravastatin ameriolates left ventricular dysfunction through inhibition of oxidative stress and inflammation in a canine model of tachycardia-induced heart failure. Circulation 104(17): 2; 247

Sibeijn, Mieke; Bouman, Aad Johannes; De Pater, Robertus Mattheus; Purmer, Cornelis Frederik 2001: HMG-CoA reductase inhibitor preparation process. Official Gazette of the United States Patent and Trademark Office Patents 1248(5)

Hayashidani, S.; Tsutsui, H.; Ide, T.; Suematsu, N.; Takeshita, A. 2000: HMG-CoA reductase inhibitor prevents left ventricular remodeling and heart failure after myocardial infarction. Journal of Molecular and Cellular Cardiology 32(11): A105

Rueckschloss, U.; Galle, J.; Zerkowski, H.R.; Holtz, J.; Morawietz, H. 2000: HMG-CoA reductase inhibitor therapy downregulates NAD H oxidase expression in internal mammary arteries of patients with coronary artery disease. Circulation 102(18): 2; 302

Ishibashi, T.; Nagata, K.; Seino, Y.; Nakazato, K.; Shindo, J.; Yokoyama, K.; Maruyama, Y. 1999: HMG-CoA reductase inhibitor, pravastatin, reduces the levels of tissue factor and plasminogen activator inhibitor-1 in human cultured monocytes. European Heart Journal 20(ABSTR Suppl ): 186

Yoshida, M.; Gerszten, R.E.; Rosenzweig, A.; Gimbrone, M.A.Jr.; Yasukochi, Y.; Numano, F. 1999: HMG-CoA reductase inhibitor-induced reduction of monocyte adhesion to vascular endothelium involves small GTP binding protein Rho dependent mechanism. Circulation 100(18): 1; 693

Marschang, P.; Friedrich, G.J.; Ditlbacher, H.; Stoeger, A.; Zur Nedden, D.; Dienstl, A.; Patsch, J.R. 2000: HMG-CoA reductase inhibitor-induced reduction of soluble P-selectin levels correlates with the progression of coronary artery disease as measured by electron beam computed tomography. Circulation 102(18): 2; 330

Wojta, J.; Wiesbauer, F.; Kaun, C.; Bodlaj, G.; Maurer, G.; Huber, K. 2000: HMG-CoA reductase inhibitors affect the fibrinolytic system of human vascular cells in vitro. Journal of Submicroscopic Cytology and Pathology 32(3): 417

Wiesbauer, F.; Kaun, C.; Bodlaj, G.; Maurer, G.; Huber, K.; Wojta, J. 2000: HMG-CoA reductase inhibitors affect the fibrinolytic system of human vascular endothelial and smooth muscle cells in vitro. Fibrinolysis and Proteolysis 14(Suppl 1): 66

Wiesbauer, F.; Kaun, C.; Bodlaj, G.; Maurer, G.; Huber, K.; Wojta, J. 2000: HMG-CoA reductase inhibitors affect the fibrinolytic system of human vascular smooth muscle cells in vitro. Journal of the American College of Cardiology 35(2 Suppl A): 311A

Stavrovskaya, E.; Kutyrina, I.; Neverov, N.; Shvetsov, M. 2002: HMG-CoA reductase inhibitors and angiotensin-converting enzyme inhibitors therapy attenuates the progression of glomerulonephritis in patients with nephrotic syndrome resistant to immunosuppressive therapy. Nephrology Dialysis Transplantation 17(Abstracts Suppl 1): 101

Senatore, M.; Buemi, M. 1999: HMG-CoA reductase inhibitors and apoptosis. Nephron 81(4): 439-440

Morales, C.E.; Bruzzi, J.F.; Chilson, T.S.; Hurley, D.L. 1999: HMG-CoA reductase inhibitors and fibric acid derivatives A dangerous combination for the treatment of hyperlipidemia. Journal of the American Geriatrics Society 47(9): S81

Robl, J.A. 2003: HMG-CoA reductase inhibitors and method. Official Gazette of the United States Patent and Trademark Office Patents 1274(3)

Ucar, M.; Mjörndal, T.; Dahlqvist, R. 2000: HMG-CoA reductase inhibitors and myotoxicity. Drug Safety 22(6): 441-457

Seliger, S.L.; Weiss, N.S.; Gillen, D.L.; Kestenbaum, B.; Ball, A.; Sherrard, D.J.; Stehman-Breen, C.O. 2002: HMG-CoA reductase inhibitors are associated with reduced mortality in ESRD patients. Kidney International 61(1): 297-304

Raggatt, L.J.; Partridge, N.C. 2002: HMG-CoA reductase inhibitors as immunomodulators: potential use in transplant rejection. Drugs 62(15): 2185-2191

Takemoto, M.; Grimm, M.; Takemoto, Y.; Liao, J.K. 2000: HMG-CoA reductase inhibitors attenuate angiotensin-II induced cardiac hypertrophy. Circulation 102(18): 2; 133

Hayashidani, S.; Tsutsui, H.; Shiomi, T.; Suematsu, N.; Weng, J. 2001: HMG-CoA reductase inhibitors attenuate left ventricular remodeling and failure after experimental myocardial infarction. Circulation 104(17): 2; 290

Nakata, M.; Yada, T.; Kakei, M. 2000: HMG-CoA reductase inhibitors block L-type Ca2+ channels, Ca2+ signaling and insulin secretion in rat islet beta-cells. Japanese Journal of Pharmacology 82(Suppl 1): 16P

Choi, M.; Rolle, S.; Rane, M.; Haller, H.; Luft, F.C.; Kettritz, R. 2001: HMG-CoA reductase inhibitors decrease ANCA-mediated activation of human neutrophils. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 588A

Horton, D.B.; Laclair, S.J.; Varo, N.; Merchant, B.C.; Kinlay, S.; Ganz, P.; Schonbeck, U. 2003: HMG-CoA reductase inhibitors diminish interstitial collagen turnover in human vascular smooth muscle cells. Circulation 108(17): IV286

Rajavashisth, T.B.; Shukla, A.K.; Shah, P.K. 2000: HMG-CoA reductase inhibitors downregulate M-CSF expression in vascular endothelial cells. Molecular Biology of the Cell 11(Suppl): 26a-27a

Schmid, R.M. 2002: HMG-CoA reductase inhibitors for the treatment of pancreatic cancer. Gastroenterology 122(2): 565-567

Miles, J.S.; Liu, Y.; Eustace, J.; Longenecker, J.C.; Fink, N.; Powe, N.R.; Tracy, R.P.; Klag, M.J.; Coresh, J. 2002: HMG-CoA reductase inhibitors have different effects on C-reactive protein and fibrinogen in patients with ESRD. Circulation 106(19): 2; 747

Wassmann, S.; Laufs, U.; Baeumer, A.T.; Mueller, K.; Ahlbory, K.; Linz, W.; Boehm, M.; Nickenig, G. 2000: HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension by reduced free radical production. Circulation 102(18): 2; 95

Buckley, B.M. 1999: HMG-CoA reductase inhibitors in atherosclerosis. Crepaldi, G, Tiengo, A, Del Prato, S International Congress Series; Insulin resistance, metabolic diseases and diabetic complications 219-224

Nair, S.; Wiseman, M. 2002: HMG-CoA reductase inhibitors in non alcoholic fatty liver disease Is their potential hepatotoxicity an issue in these patients? A case control study based on histology. Hepatology 36(4 Part 2): 409A

Schlienger, R.G.; Meier, C.R. 2003: HMG-CoA reductase inhibitors in osteoporosis: do they reduce the risk of fracture?. Drugs and Aging 20(5): 321-336

van Mil, A.H.; Westendorp, R.G.; Bollen, E.L.; Lagaay, A.M.; Blauw, G.J. 2000: HMG-CoA reductase inhibitors in the prevention of stroke. Drugs 59(1): 1-6

Toledano, J.E.; Walling, H.W.; Irvine, D.W.; Barmina, O.Y.; Burdge, R.E.; Jeffrey, J.J.; Partridge, N.C. 2000: HMG-CoA reductase inhibitors increase degradation of collagenase-3 in osteoarthritic chondrocytes. FASEB Journal 14(4): A715

Kong, D.; Park, H.J.; Tang, D.; Galper, J.B. 2000: HMG-CoA reductase inhibitors interfere with VEGF signaling in human endothelial cells. Circulation 102(18): 2; 64

Park, H.J.; Galper, J.B.; Kong, D.Q. 2001: HMG-CoA reductase inhibitors interfere with VEGF signaling in human endothelial cells Role of Rho. FASEB Journal 15(5): A742

Laufs, U.; Marra, D.E.; Liao, J.K. 1999: HMG-CoA reductase inhibitors prevent Rho GTPase-induced downregulation of cyclin-dependent kinase inhibitor p27Kip1 in vascular smooth muscle cells. Circulation 100(18): I334-I335

Perrino, Cinzia; Di Lorenzo, Emilio; Ciro, Indolfi; Curcio, Antonio; Cireddu, Manuela; Falco, Maria Cristina; Avvedimento, Enrico Vittorio; Chiariello, Massimo 2001: HMG-CoA reductase inhibitors prevent cardiac hypertrophy induced by pressure-overdload and inhibit p21Ras and RhoA signaling. Circulation 104(17): 2; 111-II 112

Danesh, F.R.; Sadeghi, M.; Zeng, L.; Kanwar, Y. 2002: HMG-CoA reductase inhibitors prevent high glucose-induced proliferation of mesangial cells via modulation of Rho GTPase/p21 signaling pathway. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 165A

D.L., E.; Indolfi, C.; Stingone, A.M.; Cioppa, A.; Perrino, C.; Curcio, A.; Arcucci, O.; Pascotto, M.; Chieffo, A.; Chiariello, M. 1999: HMG-CoA reductase inhibitors prevent the cardiac hypertrophy induced by aortic stenosis. Circulation 100(18): 1; 126

Skaletz Rorowski, A.; Lutchman, M.; Kureishi, Y.; Lefer, D.J.; Faust, J.R.; Walsh, K. 2002: HMG-CoA reductase inhibitors promote the translocation of protein kinase Akt to membrane domains in endothelial cells. European Heart Journal 23(Abstract Suppl): 372

Wassmann, S.; Nickenig, G.; Boehm, M. 1999: HMG-CoA reductase inhibitors reduce free radical production via AT1 receptor downregulation in vascular smooth muscle cells. Circulation 100(18): 1; 137

Ruperez, M.; Blanco Colio, L.; Lorenzo, O.; Esteban, V.; Egido, J.; Ruiz Ortega, M. 2002: HMG-CoA reductase inhibitors regulate angiotensin II responses via Rho proteins Modulation of connective tissue growth factor in vascular smooth muscle cells. Circulation 106(19): II124

Gotoh, A.; Ikebuchi, K.; Miyazawa, K.; Ohyashiki, K. 2003: HMG-CoA reductase inhibitors suppress activation of Rho And hematopoietic cell migration toward SDF-1 via suppression of geranylgeranylation. Blood 102(11): 827a

Ishibashi, T.; Yokoyama, K.; Kimura, J.; Matsuoka, I.; Nagata, K.; Sakamoto, T.; Maruyama, Y. 2000: HMG-CoA reductase inhibitors suppress intracellular calcium mobilization induced by lysophosphatidylcholine mediated via inhibition of Rho/ROCK pathway in endothelial cells. Circulation 102(18): 2; 320

Choi, M.; Rolle, S.; Rane, M.; Haller, H.; Luft, F.C.; Kettritz, R. 2001: HMG-CoA reductase inhibitors suppress respiratory burst in ANCA-stimulated human neutrophils. Kidney and Blood Pressure Research 24(4-6): 366

Yasuda, S.; Matzno, S.; Tanaka, H.; Tazuya Murayama, K.; Yamamoto, Y.; Uchida, T.; Nakabayashi, T.; Matsuyama, K. 2002: HMG-CoA reductase inhibitors-induced apoptosis is coupled with membrane farnesylated Ras depletion in L6 myocytes. Japanese Journal of Pharmacology 88(Suppl 1): 179P

Ueda, Y.; Kitakaze, M.; Asanuma, H.; Kuzuya, T.; Hori, M. 1999: HMG-CoA reductase pravastatin restored the infarct size-limiting effect of ischemic preconditioning blunted by hypercholesterolemia. Journal of the American College of Cardiology 33(2 Suppl A): 386A

Chun, K.Y.; Miziorko, H.M. 1999: HMG-CoA synthase A role for conserved carboxyl groups in acetyl-S-enzyme formation. FASEB Journal 13(7): A1354

Wang, C.Z.; Misra, I.; Miziorko, H.M. 2003: HMG-CoA synthase Mutagenesis and 13C NMR studies on the influence of conserved aromatic amino acids. Abstracts of Papers American Chemical Society 226(1-2): BIOL 93

Abdenur, J.E.; Chamoles, N.A.; Schenone, A.; Guinle, A.; Fusta, M.; Coluccio, M.; Lavorgna, S. 2000: HMG-CoA-lyase deficiency Response of 3-OH-isovalerylcarnitine to dietary treatment and differences in its whole blood, plasma and red blood cell levels. Journal of Inherited Metabolic Disease 23(Suppl 1): 106

Hermann, M.; Ruschitzka, F.; Shaw, S.; Luescher, T.F. 2003: HMG-CoA-reductase inhibitor improves endothelial dysfunction in senescent rats. European Heart Journal 24(Abstract Suppl): 573

Naether, M.; Leonhardt, U.; Ritzel, U.; Ramadori, G. 1999: HMG-CoA-reductase inhibitors and primary biliary cirrhosis. Gastroenterology 116(4 Part 2): A24

Hausberg, M.; Barenbrock, M.; Stam, F.; Kosch, M.; Kisters, K.; Spieker, C.; Heidenreich, S.; Rahn, K.H. 1999: HMG-CoA-reductase inhibitors improve brachial artery flow-mediated vasodilation in renal transplant recipients. Nephrology Dialysis Transplantation 14(9): A282

Aicher, A.; Vasa, M.; Mildner Rihm, C.; Adler, K.; Tiemann, M.; Ruetten, H.; Martin, H.; Dimmeler, S. 2001: HMG-CoA-reductase inhibitors increase the number of endothelial progenitor cells via the PI3 kinase/Akt pathway. Circulation 104(17): 2; 261

D.L.renzo, E.; Indolfi, C.; Perrino, C.; Stingone, A.M.; Curcio, A.; Cavuto, L.; Chieffo, A.; Feliciello, A.; Avvedimento, V.E.; Chiariello, M. 2000: HMG-Coa reductase inhibitors prevent left ventricular hypertrophy by up-regulation P27Kip1 and down-regulation of Cdk4 levels. European Heart Journal 21(Abstract Suppl): 261

Wood, L.J.; Xu, Y.; Resar, L.M.S. 2001: HMG-I/Y A c-Myc target gene and putative oncogene involved in lymphoid malignancy. Pediatric Research 49(4 Part 2): 206A

Sumoy, L.; Carim, L.; Escarceller, M.; Nadal, M.; Gratacos, M.; Pujana, M.A.; Estivill, X.; Peral, B. 1999: HMG20A and HMG20B map to human chromosomes 15q24 and 19p133 and constitute a distinct class of HMG-box genes with ubiquitous expression HMG20A HMG20B. American Journal of Human Genetics 65(4): A381

Cerignoli, F.; Ambrosi, C.; Gulino, A.; Giannini, G. 2003: HMGA proteins regulate retinoic acid response in human neuroblasoma cell lines. FASEB Journal 17(4-5): Abstract 410

Hommura, F.; Katabami, M.; Leaner, V.D.; Donninger, H.; Resar, L.M.S.; Reeves, R.; Birrer, M.J. 2003: HMGA1 is a cJun responsive gene and is necessary for cJun induced anchorage-independent growth. Proceedings of the American Association for Cancer Research Annual Meeting 44: 631

Agresti, A.; Bianchi, M.E. 2003: HMGB proteins and gene expression. Current Opinion in Genetics and Development 13(2): 170-178

Yang, H.; Wang, H.C.; Czura, C.J.; Tracey, K.J. 2002: HMGB1 as a cytokine and therapeutic target in systemic inflammation. Journal of Endotoxin Research 8(3): 229-230

Andersson, U.; Tracey, K.J. 2004: HMGB1 as a mediator of necrosis-induced inflammation and a therapeutic target in arthritis. Rheumatic Diseases Clinics of North America 30(3): 627

Limana, F.; Germani, A.; Palumbo, R.; Anversa, P.; Bianchi, M.; Capogrossi, M.C. 2003: HMGB1 induces myocardial regeneration and functional recovery of the infarcted heart. Circulation 108(17): IV204

Feron, O.J.; Desager, J.P.; Balligand, J.L. 1999: HMGCoA reductase inhibition promotes NO production by decreasing the abundance and the inhibitory interaction of caveolin with the endothelial nitric oxide synthase. Circulation 100(18): I336-I337

Fletcher, J.; Xiao, S. 2000: HMGI -LAMA4* fusion oncogene, oncoprotein and methods of use. Official Gazette of the United States Patent and Trademark Office Patents 1240(3)

Huttenbach, Y.; Ramzy, I.; Mann, S.; Liu, L.; Chirala, M.; Younes, M. 2003: HMGI expression is a specific marker of malignancy in thyroid cytologic preparations. Modern Pathology 16(1): 70A

Chada, K.K.; Ashar, H.; Tkachenko, A.; Zhou, X. 2001: HMGI proteins in cancer. Official Gazette of the United States Patent and Trademark Office Patents 1242(2)

Chada, K.K.; Ashar, H.; Tkachenko, A.; Zhou, X. 2004: HMGI proteins in cancer and obesity. Official Gazette of the United States Patent and Trademark Office Patents 1283(5)

Van, D.Ven, W.J.M. 2001: HMGI target genes encoding secreted proteins as potential early-warning markers in carcinomas. International Journal of Molecular Medicine 8(Suppl 1): S92

Tallini, G.; Vanni, R.; Manfioletti, G.; Kazmierczak, B.; Faa, G.; Pauwels, P.; Bullerdiek, J.; Giancotti, V.; Van Den Berghe, H.; Dal Cin, P. 2000: HMGI-C and HMGI(Y) immunoreactivity correlates with cytogenetic abnormalities in lipomas, pulmonary chondroid hamartomas, endometrial polyps, and uterine leiomyomas and is compatible with rearrangement of the HMGI-C and HMGI(Y) genes. Laboratory Investigation; a Journal of Technical Methods and Pathology 80(3): 359-369

Szabolcs, M.J.; Chada, K.; D'armiento, J. 2002: HMGI-C expression is linked to invasion and metastasis in colorectal carcinoma. Laboratory Investigation 82(1): 146A

Nucci, M.R.; Tallini, G.; Quade, B.J. 2001: HMGIC expression as a diagnostic marker for vulvar Aggressive Angiomyxoma. Laboratory Investigation 81(1): 142A

Bullerdiek, J.; Kazmierczak, B.; Rogalla, P.; Rommel, B. 1999: HMGIC rearrangements in benign solid tumors Can we close the X-files?. Cytogenetics and Cell Genetics 85(1-2): 25

Koerner, U.; Bustin, M.; Scheer, U.; Hock, R. 2001: HMGN2 prolonges mesodermal competence in early Xenopus embryos. Biology of the Cell 93(3-4): 202

Maeda, N.; Sano, Y.; Nagata, H.; Fu, K.I.; Yoshino, T.; Okuno, T.; Kato, S.; Yoshida, S.; Ochiai, A.; Fujii, T. 2002: HMLH-1 protein expression is reduced in large hyperplastic polyps of the colorectum. Gastroenterology 122(4 Suppl 1): A-119

Zuo, C.; Ai, L.; Mukunyadzi, P.; Suen, J.Y.; Hanna, E.; Fan, C.Y. 2003: HMLH1 DNA mismatch repair gene in head and neck squamous cell carcinoma Promoter methylation and loss of protein expression with clinical correlation in 94 patients. Modern Pathology 16(1): 223A

Judd, R.; Caplan, S.; Sittler, S.; Kratz, A. 2002: HMLH1 and hMSH2 DNA mismatch repair activity in colorectal carcinomas and correlation with p53, HER-2, and EGFR expression. Laboratory Investigation 82(1): 130A-131A

Sedivy, R.; Kurzbauer, R.; Muehlbacher, F.; Huber, L.A.; Wrba, F. 2001: HMLH1 and hMSH2 expression in an osteoclast-like giant cell tumour of the pancreas associated with mucinous cystadenocarcinoma. Virchows Archiv 439(3): 460

Wang, L.; Roberts, L.R.; Roche, P.C.; Thibodeau, S.N.; Burgart, L.J. 2000: HMLH1 and hMSH2 expression in hepatocellular carcinoma. Proceedings of the American Association for Cancer Research Annual Meeting 41: 124

Liloglou, T.; George, X.; Wendy, P.; Maloney, P.; Callaghan, J.; Fielding, P.; Gosney, J.R.; Field, J.K. 2000: HMLH1 and hMSH2 expression in non-small cell lung carcinomas correlates with allelic imbalance on chromosome 3p. Proceedings of the American Association for Cancer Research Annual Meeting 41: 188-189

Thompson, M.J.; Parkinson, C.; Berney, D.M.; Colville, C.; Bibby, M.C. 2000: HMLH1 and hMSH2 expression in pre- and post-chemotherapy clinical testicular tissues. Proceedings of the American Association for Cancer Research Annual Meeting 41: 273

Holinski Feder, E.; Mller Koch, Y.; Neitzel, B.; Kopp, R.; Lohse, P.; Gross, M.; Baretton, G.; Kerker, B.; Neuschfer, C.; Wirtz, A.; Murken, J. 1999: HMLH1 and hMSH2 mutation analysis in 112 suspected HNPCC families. American Journal of Human Genetics 65(4): A130

Giraldo, A.; Gomez, A.; Salguero, A.; Garcia, H.; Aristizabal, F.; Gutierrez, O.; Angel, L.A.; Padron, J.; Martinez, C.; Martinez, H.; Malaver, O.; Florez, L.; Barvo, R. 2003: HMLH1 and hMSH2 mutations in Colombian families with HNPCC Description of two novel mutations. American Journal of Human Genetics 73(5): 230

Hardisson, D.; Moreno Bueno, G.; Sanchez, L.; Farre, X.; Sarrio, D.; Suarez, A.; Sanchez, B.A.; Calero, F.; Palacios, J. 2003: HMLH1 and hMSH2 protein expression in endometrial carcinoma and atypical endometrial hyperplasia on tissue microarray Relationship with microsatellite instability. Modern Pathology 16(1): 191A

Paulsen, C.A.; Slattery, M.L.; Samowitz, W.S. 2003: HMLH1 expression in hyperplastic polyps of the proximal colon. Modern Pathology 16(1): 131A

Kang, G.H.; Shim, Y.H.; Jung, K.C.; Jung, H.Y.; Ro, J.Y. 2000: HMLH1 promoter hypermethylation in multiple gastric carcinoma with high frequency of microsatellite instability. Laboratory Investigation 80(3): 82A

Esteller, M.; Sanchez Cespedes, M.; Sidransky, D.; Baylin, S.B.; Herman, J.G. 2000: HMLH1 promoter hypermethylation outside HNPCC-associated tumors The case of leukemias. Proceedings of the American Association for Cancer Research Annual Meeting 41: 125-126

Peiro, G.; Diebold, J.; Mayr, D.; Baretton, G.; Kimmig, R.; Schmidt, M.; Loehrs, U. 2000: HMLH1, hMSH2 and BAX protein expression in sporadic endometrial carcinoma. Laboratory Investigation 80(3): 130A

Zheng, J.; Venkataramanan, L.; Sigworth, F.J. 1999: HMM analysis of subconductance levels during deactivation of Shaker channels. Biophysical Journal 76(1 Part 2): A415

Medina Gundrum, L.; Gomez, L.R.; Cerna, C.Z.; Piazza, G.A. 2002: HMN-176 exhibits marked anticancer activity in an ex-vivo human tumor colony formation assay. Proceedings of the American Association for Cancer Research Annual Meeting 43: 79-80

Dulai, Gareth S.; Ganz, Patricia; Kahn, Katherine; Farmer, Melissa; Dietrich, Allen; Malin, Jennifer; Da Costa, Irene; Qi, Karen 2001: HMO organizational structure and colorectal cancer screening practices. Gastroenterology 120(5 Suppl 1): A 405

Koves, P.; Szakacs, Z.; Bernath, I.; Molnar, M. 2002: HMPAO SPECT and neuropsychological examinations in OSAS patients Treated with CPAP. Journal of Sleep Research 11(Suppl 1): 127-128

Pupi, A.; Sestini, S.; De Cristofaro, M.T.R.; Emmi, L.; Marchione, T.; Meldolesi, U.; Sciagra, R. 1999: HMPAO study with acetazolamide demonstrates that gray-matter hypoperfusion areas in Behcet disease are chiefly due to disconnection. Journal of Nuclear Medicine 40(5 Suppl): 142P

Goegelein, H.; Englert, H.C.; Kotzan, A.; Hack, R.; Lehr, K.H.; Seiz, W.; Becker, R.H.A.; Sultan, E.; Schoelkens, B.A.; Busch, A.E. 2000: HMR 1098 An inhibitor of cardiac ATP-sensitive potassium channels. Cardiovascular Drug Reviews 18(2): 157-174

Dendorfer, A.; Englert, H.; Wirth, K.; Tempel, K.; Dominiak, P. 2001: HMR 1372, a putative inhibitor of ATP-sensitive K+-channels, reduces infarct size by a cholinergic mechanism. Naunyn-Schmiedeberg's Archives of Pharmacology 363(4): R74

Billman, G.E.; Houle, M.S.; Englert, H.C.; Goegelein, H.; Busch, A.E. 2000: HMR 1402, a novel cardioselective ATP-sensitive potassium channel antagonist, prevents ventricular fibrillation induced by myocardial ischemia. Circulation 102(18): 2; 209

Billman, G.E.; Houle, M.S.; Gerlach, U.; Englert, H.C.; Goegelein, H.; Busch, A. 2000: HMR 1402, a novel cardioselective ATP-sensitive potassium channel antagonist, protects against ischaemically-induced ventricular fibrillation. European Heart Journal 21(Abstract Suppl): 326

Dix, R.; Gerken, M.; Woessner, R.; Bolen, J.B. 1999: HMR 1826 A new doxorubicin prodrug; Biological aspects. Abstracts of Papers American Chemical Society 217(1-2): CARB 62

Gerken, M. 1999: HMR 1826 A new doxorubicin-prodrug; synthetic aspects. Abstracts of Papers American Chemical Society 217(1-2): CARB 61

Yang, X.M.; Downey, J.M.; Cohen, M.V. 1999: HMR 1883, a surface KATP channel antagonist, blocks protection from diazoxide Diazoxides specificity for mitochondrial KATP is questionable. Circulation 100(18): 1; 342

Muller Serieys, C.; Cantalloube, C.; Soler, P.; Gia, H.P.; Brunner, F. 1999: HMR 3647 achieves high and sustained concentrations in broncho-pulmonary tissues. Journal of Antimicrobial ChemoTherapy 44(Suppl A): 57

Gia, H.P.; Roeder, V.; Namour, F.; Sultan, E.; Lenfant, B. 1999: HMR 3647 achieves high and sustained concentrations in white blood cells in man. Journal of Antimicrobial ChemoTherapy 44(Suppl A): 57-58

Labbe, G.; Flor, M.; Lenfant, B. 1999: HMR 3647, a new ketolide antimicrobial, does not inhibit cytochrome P450 activity in vitro. Journal of Antimicrobial ChemoTherapy 44(Suppl A): 61

Sultan, E.; Namour, F.; Mauriac, C.; Lenfant, B.; Scholtz, H. 1999: HMR 3647, a new ketolide antimicrobial, is metabolised, and excreted mainly in faeces in man. Journal of Antimicrobial ChemoTherapy 44(Suppl A): 54

Costa, A.D.; Dos Santos, P.; Garlid, K.D. 2004: HMR1098 blocks mitoKATP opening by diazoxide but not by other K+-channel openers in isolated heart mitochondria. Biophysical Journal 86(1): 462a

Doucet, B.; Auberval, M.; Gourvest, J.; Bouali, Y.; Da Ponte, F.; Lepescheux, L.; Bardelay, C.; Bouchoux, F.; Viet, S.; Peyman, A.; Gadek, T.; Bodary, S.; Gaillard, M.; Baron, R. 2000: HMR1392 In vivo anti-resorptive activity of a new high affinity nonpeptide alpha-v beta3 integrin ligand. Journal of Bone and Mineral Research 15(Suppl 1): S393

Vallon, V.; Huang, D.Y.; Gerlach, U.; Richter, K. 2003: HMR1556, a blocker of potassium channel forming KCNQ1, inhibits glucose absorption in proximal tubule. Naunyn-Schmiedeberg's Archives of Pharmacology 367(Suppl 1): R108

Dodds, R.A.; Jennings, M.; Young, R.; Kostura, L.; Zhou, W.S.; Cooper, L.F. 2002: HMSCs-host interactions in ectopic bone formation. Journal of Bone and Mineral Research 17(Suppl 1): S340

Markwalder, R.; Prtilo, A.; Leach, F.S.; Kappeler, A.; Wetterwald, A.; Burkhard, F.C.; Klima, I.; Studer, U.E.; Cecchini, M.G.; Thalmann, G.N. 2004: HMSH2 expression analysis in tumour tissue microarray predicts outcome and survival of patients with prostate cancer. European Urology Suppls 3(2): 116

Parc, Y.R.; Halling, K.C.; Wang, L.; Christensen, E.R.; Cunningham, J.M.; Burgart, L.J.; Price Troska, T.L.; Thibodeau, S.N. 1999: HMSH6 alterations in patients with MSI-L colorectal cancer. American Journal of Human Genetics 65(4): A65

Barton, D.E.; Rowland, J.S.; Taylor, G.R. 1999: HMSN1 A UK-wide comparative study of dosage analysis methods. American Journal of Human Genetics 65(4): A57

Ellis, C.E.; Halsey, W.; Sathe, G.M.; Ames, R.S.; Foley, J.J.; Sarau, H.M.; Chambers, J. 2003: HMTF81 human 7-transmembrane receptor. Official Gazette of the United States Patent and Trademark Office Patents 1266(2)

Xiang, Z.G.; Jiang, D.D.; Liu, Y.; Zhang, L.F.; Zhu, L.P. 2010: HMan2c1 transgene promotes tumor progress in mice. Transgenic Research 19(1): 67-75

Tseng, G.N.; Abbott, G.; Jiang, M. 2000: HMiRP1 modulates the gating kinetics and pharmacology of transient outward current. Circulation 102(18): 2; 285

Weerapura, M.; Hebert, T.; Nattel, S. 2000: HMiRP1-HERG association does not account for discrepancies with native IKr channels in response to class III drugs. Circulation 102(18): 2; 24

Maher, V.M.; Li, Z.; Mccormick, J.J.; Xiao, W. 2002: HMms2, a protein essential for a major error-free pathway by which human cells avoid replicating past fork-blocking DNA damage. Environmental and Molecular Mutagenesis 39(Suppl 33): 40

Camacho, E.; Hernandez, L.; Bea, S.M.; Camps, J.; Colomer, D.; Miro, R.; Campo, E. 2003: HMps1 and BTAK/Aurora 2 mitotic kinases are deregulated in lymphoid cancer cell lines. Proceedings of the American Association for Cancer Research Annual Meeting 44: 22

Skotko, B.; Einstein, G.; Rubin, D.; Tupler, L.; Locascio, J.J.; Corkin, S. 1999: HMs puzzling experience. Society for Neuroscience Abstracts 25(1-2): 894

Liu, D.; Tonkovich, G.S.; Halayko, A.; Li, B.; Camoretti Mercado, B.; Solway, J.; Kyle, J.W. 1999: HNAV21 Na channels in cultured human airway smooth muscle. Biophysical Journal 76(1 Part 2): A197

Lipovich, L.; Opitz, J.M.; Morrow, J.; Lee, M.K.; Person, R.; King, M.C.; Lynch, E.D. 1999: HNBCoi A novel Na+/HCO3- cotransporter in the 5q region linked to ovarian dysgenesis and sensorineural deafness. American Journal of Human Genetics 65(4): A476

Iles, K.E.; Dickinson, D.A.; Wigley, A.F.; Welty, N.E.; Forman, H.J. 2003: HNE induces HO-1 through activation of the ERK and JNK pathways in alveolar type II cells. Free Radical Biology and Medicine 35(Suppl 1): S67

Magni, F.; Ferrarese, C.; Cattaneo, A.; Galbusera, C.; Begni, B.; Zoia, C.; Brighina, L.; Kienle, M.G. 2001: HNE-Abeta adducts evaluated in vitro and in washed platelets by HPLC-ESI-MS. Clinical Chemistry and Laboratory Medicine 39(Special Suppl): S123

Divine, J.; Simon, T. 2002: HNF-1 and GATA family transcription factors cooperate to regulate expression of the rat liver fatty acid binding protein gene in the intestinal epithelium. Gastroenterology 122(4 Suppl 1): A-522

Divine, J.K.; Mccaul, S.P.; Simon, T.C. 2001: HNF-1alpha and HNF-1beta regulate transcriptional activation of the rat liver fatty acid binding protein gene in liver, intestine, and kidney by distinct interactions with Cdx, C/EBP, GATA, HNF-3, and HNF-4 family transcription factors. Gastroenterology 120(5 Suppl 1): A 123

Diamantis, I.; Karamitopoulou, E.; Christodoulopoulos, G.; Valatas, V.; Notas, G.; Tsirogianni, I. 2003: HNF-1alpha and vHNF genes are up regulated in livers of CCL4 treated rats. Journal of Hepatology 38(Suppl 2): 76

Shih, D.Q.; Bussen, M.; Sehayek, E.; Breslow, J.L.; Stoffel, M. 2001: HNF-1alpha is an essential regulator of bile acid and plasma cholesterol metabolism. Diabetes 50(Suppl 2): A8

Park, Y.M.; Lee, G.T.; Jun, S.; Park, C.W.; Lee, H.L. 2003: HNF-1alpha transactivates the L-PK proximal promoter differentially in a HNF-1alpha producing cell-type dependent manner. Diabetologia 46(Suppl 2): A131

Boudreau, F.; Rings, E.H.H.M.; Van Wering, H.; Swain, G.P.; Krasinski, S.D.; Suh, E.; Grand, R.J.; Traber, P.G. 2002: HNF-1alpha, GATA-4 and Cdx2 functionally interact to stimulate sucrase-isomaltase gene expression. Gastroenterology 122(4 Suppl 1): A 21

Leinemann, U.; Knepel, W. 2001: HNF-3beta contributes to species-specific differences of human and rat glucagon gene transcription. Experimental and Clinical Endocrinology and Diabetes 109(Suppl 1): S45

Stepanian, S.V.; Huyn, S.T.; Mccabe, E.R.B.; Dipple, K.M. 2002: HNF-4 alpha enhances expression of human glycerol kinase in a human hepatocellular carcinoma cell line. American Journal of Human Genetics 71(4 Suppl): 325

Hegele, R.A.; Hanley, A.J.G.; Zinman, B.; Harris, S.B.; Cao, H. 2000: HNF1A G319S mutation associated with high type 2 diabetes mellitus rate and excessive coronary heart disease in Ontario Oji-Cree. Circulation 102(18): 2; 859

Gresh, L.; Fischer, E.; Barra, J.; Fiette, L.; Babinet, C.; Igarashi, P.; Yaniv, M.; Pontoglio, M. 2003: HNF1beta plays sequential roles during kidney morphogenesis in mouse. Journal of the American Society of Nephrology 14(Abstracts Issue): 364A

Wong, G.W.; Yao, K M. 1999: HNF3 delta compositions. Official Gazette of the United States Patent and Trademark Office Patents 1218(3): 2180

Wang, H.; Gauthier, B.; Wollheim, C.B. 2001: HNF3b is required for maintaining a-cell phenotype but not b-cell gene expression in differentiated islet cells. Diabetologia 44(Suppl 1): A 71

Stafford, J.M.; Wang, J.C.; Scott, D.K.; Sugiyama, T.; Granner, D.K. 2000: HNF4 as a liver gene transcription factor. Matschinsky, F M Author, Magnuson, M A Author Frontiers in Diabetes; Molecular pathogenesis of MODYs 235-250

Dipple, K.M.; Stepanian, S.V.; Huyn, S.T.; Mccabe, E.R.B. 2003: HNF4 binds the human glycerol kinase promoter and activates transcription of glycerol kinase. Journal of Inherited Metabolic Disease 26(Suppl 2): 187

Bell, A.W.; Runge, D.; Michalopoulos, G. 2000: HNF4 transcriptional regulation in matrix-induced hepatocyte differentiation. Hepatology 32(4 Pt 2): 332A

Kurdi Haidar, B.; Duncan, S.A.; Battle, M.A.; Deeb, S.S. 2003: HNF4alpha is essential for expression of the human hepatic lipase gene in vivo HNF4alpha and ARP-1 bind to DR1 and DR4 elements of the promoter and fine-tune its activity in vitro. American Journal of Human Genetics 73(5): 352

Wang, H.; Maechler, P.; Hagenfeldt, K.A.; Wollheim, C.B. 2000: HNF4alpha regulates pancreatic beta-cell gene expression and metabolism-induced insulin secretion. Diabetologia 43(Suppl 1): A23

Kulkarni, R.N.; Kahn, C.R.nald 2004: HNFs Linking the liver and pancreatic islets in diabetes. Science 303(5662): 1311-1312

Che, J.; Doubrovin, M.; Osborne, J.; Serganova, I.; Ageyeva, L.; Gelovani Tjuvajev, J.; Blasberg, R. 2003: HNIS-ires-GFP dual reporter gene imaging. Journal of Nuclear Medicine 44(5 Suppl): 28P

Chou, D.K.H.; Henion, T.R.; Jungalwala, F.B. 2002: HNK-1 carbohydrate synthesis in retinoic acid-induced P19 cells. Journal of Neurochemistry 81(Suppl 1): 95

Oka, S.; Kawasaki, T. 2002: HNK-1 glucuronyltransferase. Taniguchi, Naoyuki, Honke, Koichi, Fukuda, Minoru Handbook of glycosyltransferases and related genes Edition 1 359-367

Bakker, H. 2002: HNK-1 sulfotransferase. Taniguchi, Naoyuki, Honke, Koichi, Fukuda, Minoru Handbook of glycosyltransferases and related genes Edition 1 451-456

Depaz, I.M.; Jaquet, V.; Wilce, P.A. 2001: HNP22 expression levels are increased during alcohol withdrawal. Journal of Neurochemistry 78(Suppl 1): 82

Terdiman, J.P. 2001: HNPCC: an uncommon but important diagnosis. Gastroenterology 121(4): 1005-1008

Mansoor, S.; Intengan, M.E.; Brooks, J.J.; Weber, T.K.; Petrelli, N.J.; Yamamoto, H.; Perucho, M.; Rodriguez Bigas, M.A. 1999: HNPCC Correlation of hMSH2 and hMLH1 expression with somatic and genomic alterations in mismatch repair genes. Modern Pathology 12(1): 80A

Delozier Blanchet, C.D.; Blouin, J.L.; Brundler, M.A.; Egger, J.F.; Hutter, P.; Soravia, C. 2000: HNPCC Efficient diagnosis and management require a pluridisciplinary network. American Journal of Human Genetics 67(4 Suppl 2): 82

Lynch, H.T.; Lin, K.; Smyrk, T.; Watson, P.; Thorson, A.; Shashidharan, M.; Franklin, B.; Karr, B.; Lynch, J.F.; Tinley, S.; Lanspa, S.; Lemon, S.J.; Shaw, T.; Rodriguez Bigas, M.A. 1999: HNPCC Genetics, counseling, natural history, surveillance, and management. Utsunomiya, J , Mulvihill, J J , Weber, W Familial cancer and prevention: Molecular epidemiology: A new strategy toward cancer control 197-206

Mueller Koch, Y.; Vogelsang, H.; Keller, G.; Kopp, R.; Lohse, P.; Gross, M.; Schiemann, U.; Baretton, G.; Aust, D.; Kerker, B.; Henke, G.; Daum, J.; Holinski Feder, E. 2002: HNPCC Two different entities in regard of mutation analysis and clinical phenotype. European Journal of Human Genetics 10(Suppl 1): 110

Frayling, I.; Payne, S.J.; Bell, J.A.; Cook, J.A.; Maher, E.R.; Mackay, J.; Tomlinson, I.P.M.; Whittaker, J.L. 2000: HNPCC or attenuated FAP? Lessons from a colorectal cancer family with MSH2 T905R and APC R332X. Journal of Medical Genetics 37(Suppl 1): S37

Velardo, M.J.; O'steen, B.E.; Mcgrogan, M.; Reier, P.J. 2000: HNT cells and transplantation repair of rat cervical spinal cord contusions. Experimental Neurology 164(2): 454

Snable, G.L. 2000: HNT-neuron human neuronal cells to replace ganglion cells. Official Gazette of the United States Patent and Trademark Office Patents 1241(3)

Yachie, A.; Toma, T.; Shimura, S.; Ohta, K.; Kasahara, Y.; Koizumi, S. 2000: HO-1 expression by gene transfer reverses hemin-induced cell injury of lymphoblastoid cell lines derived from a HO-1 deficient patient. Acta Haematologica (Basel) 103(Suppl 1): 100

Vanella, L.; Kim, D.H.; Asprinio, D.; Peterson, S.J.; Barbagallo, I.; Vanella, A.; Goldstein, D.; Ikehara, S.; Kappas, A.; Abraham, N.G. 2010: HO-1 expression increases mesenchymal stem cell-derived osteoblasts but decreases adipocyte lineage. Bone 46(1): 236-243

Taller, D.R.; Papoiu, A.; Goodman, A.; Abraham, N.G. 2004: HO-1 induction attenuates oxidant generation and downregulates PKC beta II expression in pancreatic islet cells. FASEB Journal 18(4-5): Abstract 858

Kotsch, K.; Kordic, M.; Buelow, R.; Tullius, S.G.; Volk, H.D.; Neuhaus, P.; Pratschke, J. 2002: HO-1 induction in brain dead donors leads to improved organ survival. Human Immunology 63(Suppl 1): S67

Seyfried, S.; Sass, G.; Yamashita, K.; Soares, M.P.; Tiegs, G. 2003: HO-1 induction protects mice from immune-mediated liver injury. Naunyn-Schmiedeberg's Archives of Pharmacology 367(Suppl 1): R80

Upton, R.L.; Gutteridge, J.M.C.; Anning, P.B.; Evans, T.W.; Quinlan, G.J. 2000: HO-1 is involved in the regulation of IRP-1 activity in rat lung Implications for microbial virulence and lung injury. Thorax 55(Suppl 3): A68

Song, W.; Su, H.; Song, S.; Paudel, H.K.; Schipper, H.M. 2004: HO-1 over-expression promotes oxidative mitochondrial damage in rat astroglia. FASEB Journal 18(4-5): Abstract 858

Pileggi, A.; Cattan, P.; Berney, T.; Molano, R.D.; Vizzardelli, C.; Ricordi, C.; Bach, F.H.; Inverardi, L. 2001: HO-1 upregulation protects the pancreatic cell line betaTC3 from cytokines and Fas-induced apoptosis. Transplantation Proceedings 33(1-2): 266-267

Clark, J.E.; Foresti, R.; Green, C.J.; Motterlini, R. 2000: HO-1-derived bilirubin Dynamics of protection against oxidative stress. Acta Haematologica (Basel) 103(Suppl 1): 83

Solomonik, I.; Simhon, D.; Braiman Wiksman, L.; Harel, A.; Haim, N.; Shik, D.; Sampson, S.; Tennenbaum, T. 2003: HO/01/2002, a new agent, dramatically improves wound closure and healing. Journal of Investigative Dermatology 121(1): 1203

Zhao, C.; Xia, C.; Derose, E.; Forsterling, F.H.; Petering, D.H. 1999: HO2-Co Bleomycin-DNA structure Site specific binding, stability, and axial ligation. Journal of Inorganic Biochemistry 74(1-4): 349

Prawitt, D.; Bahn, A.; Enklaar, T.; Fees, S.; Hauser, H.; Brixel, L.; Spangenberg, C.; Quondamatteo, F.; Hillemann, A.; Herken, R.; Burckhardt, G.; Zabel, B.U. 2001: HOAT1, a novel organic anion transporter in kidney. American Journal of Human Genetics 69(4 Suppl): 357

Zhang, W.J.; Marx, S.K.; Laue, C.; Hyder, A.; Juergensen, A.; Bickel, M.; Schrezenmeir, J. 2000: HOE 077 reduces fibrotic overgrowth around the barium alginate microcapsules. Transplantation Proceedings 32(1): 206-209

Witthaus, E.; Bradley, C.; Stewart, J. 1999: HOE 901 improves satisfaction with intensified insulin treatment for type 1 diabetes. Diabetologia 42(Suppl 1): A235

Tran, Lien Q.; Anderson, Steven E.; O.&&amp&n39.; Donnell, Martha E. 2004: HOE-642 and Bumetanide Reduce Edema Formation and Infarct Following Permanent Rat Middle Cerebral Artery Occlusion. FASEB Journal 18(4-5): Abstract 693

Anderson, S.; Beyschau, A.; Liu, H.; Cala, P.M. 1999: HOE694 limits injury in newborn cardioplegia. FASEB Journal 13(5 Part 2): A1078

Wang, L.; Renault, G.; Garreau, H.; Jacquet, M. 2001: HOG and PKA pathway are co-controlling the osmotic stress response in S cerevisiae. Biology of the Cell 93(3-4): 229

Lee, J.Y.; Lee, S.H.; Yun, D.J. 2001: HOG pathway dependent regulation of Agp2, an yeast carnitine transporter. Plant and Cell Physiology 42(Suppl): s211

Plemenitas, A.; Gorjan, A.; Gunde Cimerman, N.; Turk, M. 2003: HOG signaling pathway in halophilic black yeast Hortaea werneckii. Yeast 20(Suppl 1): S207

Toyokuni, S.; Kondo, S.; Tanaka, T.; Hiai, H.; Onodera, H.; Imamura, M. 1999: HOGG1 overexpression and high 8-oxo-2-deoxyguanosine lyase activity in human colorectal carcinoma. Free Radical Biology and Medicine 27(Suppl 1): S149

Wikman, H.; Risch, A.; Thiel, S.; Schmezer, P.; Drings, P.; Dienemann, H.; Kayser, K.; Schulz, V.; Spiegelhalder, B.; Bartsch, H. 2000: HOGG1 polymorphism and lung cancer risk in a Caucasian population A pilot study. Proceedings of the American Association for Cancer Research Annual Meeting 41: 598

Fukushima, T.; Sasaki, T.; Tsunoda, S.; Fujimoto, S.; Horike, H.; Hatta, H.; Kashihara, N. 2000: HOGG1 polymorphism correlates with progression of IgA nephropathy. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 60A-61A

Fukushima, T.; Sasaki, T.; Tsunoda, S.; Fujimoto, S.; Horike, H.; Hatta, H.; Kashihara, N. 2000: HOGG1 polymorphism is correlated with pathogenesis of diabetic nephropathy. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 114A

Taverna, M.; Pacher, N.; Bruzzo, F.; Slama, G. 1999: HOMA as a predictor of insulin requirement in type 2 diabetes with apparent secondary sulfonylureas failure. Diabetes 48(Suppl 1): A356

Shoji, T.; Emoto, M.; Nishizawa, Y. 2001: HOMA index to assess insulin resistance in renal failure patients. Nephron 89(3): 348-349

Del Natale, M.; Hermans, M.P.; Deprez, P.H. 2000: HOMA-modelling of beta-cell function and insulin sensitivity in subjects with chronic pancreatitis. Gastroenterology 118(4 Suppl 2 Pt 1): AGA A419

Yi, F.; Zhang, Y.; Janscha, J.L.; Li, P.L.; Zou, A.P. 2004: Homocysteine Activates Nadh Oxidase through Ceramide-Stimulated Rac Gtpase Activity in Rat Renal Mesangial cells. FASEB Journal 18(4-5): Abstract 644

Philibert, R.A.; Sandhu, H.K.; Hutton, A.M.; Wang, Z.; Arndt, S.; Andreasen, N.C.; Crowe, R.; Wassink, T. 2000: HOPA polymorphisms are associated with an increased risk for hypothyroidism and psychosis. American Journal of Human Genetics 67(4 Suppl 2): 341

Goldmann, T.; Umland, O.; Ulmer, A.J.; Vollmer, E. 2003: HOPE A new fixing technique and its applications for cytology. Pathology Research and Practice 199(4): 210

Wiedorn, K.H.; Olert, J.; Goldmann, T.; Kuehl, H.; Vollmer, E. 2001: HOPE A new fixing technique for human tissues and its application in molecular pathology. Pathology Research and Practice 197(5): 287

Wiedorn, K.H.; Olert, J.; Goldmann, T.; Kuehl, H.; Bosse, A.; Vollmer, E. 2002: HOPE fixing technique Improved methods enable high molecular weight DNA and RNA isolation of 20 kb from HOPE-fixed paraffin-embedded tissues. Pathology Research and Practice 198(3): 163

Anon 1999: HOPE for cardiovascular disease prevention with ACE-inhibitor ramipril. Lancet (North American Edition) 354(9181): 841

Mcclead, R.E.; Mcgregor, M.L.; Bremer, D.; Cole, C.; Fellows, R.; Phelps, D.; Oden, N.; Hope Rop Study Group 2000: HOPE-ROP study ROP outcome in infants with prethreshold ROP and SpO2 94% in room air. Pediatric Research 47(4 Part 2): 415A

Baguna, J.; Salo, E.; Tauler, J.; Jimenez, E.; Bayascas, J.R.; Garcia Fernandez, J. 1999: HOX and para-HOX genes in flatworms. American Zoologist 39(5): 88A

Grenier, J.K. 1999: HOX genes in the Ecdysozoa. American Zoologist 39(5): 88A

Capra, V.; Moroni, A.; De Marco, P.; Merello, E.; Arata, L.; Crippa, M.; Blasi, F.; Cama, A. 2001: HOX-B1 allelic variants in hindbrain malformations. American Journal of Human Genetics 69(4 Suppl): 341

Kroon, E.; Yao, J.; Sauvageau, G. 2001: HOX-PBX interaction is not required for the induction of AML by NUP98-HOXA9 or HOXA9. Blood 98(11 Part 1): 95a-96a

Meyer, A.; Malaga Trillo, E. 1999: HOX-clusters, genome duplications, and the evolution of diversity in vertebrate body plans. American Zoologist 39(5): 89A

Owens, B.M.; Spain, L.M.; Hawley, T.S.; Hawley, R.G. 2002: HOX11 Arrests Thymocyte Development at the Double Negative Stage of T Cell Differentiation. Blood 100(11): Abstract No. 565

Cave, H.; Suciu, S.; Preudhomme, C.; Poppe, B.; Robert, A.; Uyttebroek, A.; Malet, M.; Boutard, P.; Benoit, Y.; Mauvieux, L.; Lutz, P.; Mechinaud, F. 2002: HOX11L2 Expression Linked to t Is Not Associated with Poor Prognosis in Childhood T-ALL Treated in EORTC Trials 58 881 and 58 951. Blood 100(11): Abstract No. 576

Buske, C.; Feuring Buske, M.; Antonchuk, J.; Rosten, P.; Hogge, D.E.; Eaves, C.J.; Humphries, R.K. 2000: HOXA10-overexpression causes severe perturbations in human hematopoiesis. Experimental Hematology 28(7 Suppl 1): 84

Garcia Manero, G.; Daniels, J.; Mannari, R.; Chen, X.; Kantarjian, H.M.; Issa, J.P.erre 2001: HOXA5 is hypermethylated at a high frequency and density in human leukemias. Proceedings of the American Association for Cancer Research Annual Meeting 42: 345

Antonchuk, J.; Sauvageau, G.; Humphries, R.K. 2001: HOXB4 overexpression enhances in vitro expansion of hematopoietic stem cells. Experimental Hematology 29(8 Suppl 1): 106

Shen, W.; Fischbach, N.; Daniel, C.J.; Krishnan, K.; Lawrence, H.J.; Corey, L. 2003: HOXB6 protein is associated with CBP and represses erythropoiesis by reducing chromatin acetylation. Blood 102(11): 571a

Felicetti, F.; Bottero, L.; Meccia, E.; Melani, C.; Stoppacciaro, A.; Peschle, C.; Colombo, M.P.; Care, A. 2000: HOXB7 A key factor for tumor associated angiogenic switch. Tumori 86(4 Suppl 1): 12

Jave Suarez, L.F.; Winter, H.; Langbein, L.; Rogers, M.A.; Schweizer, J. 2001: HOXC13 regulates the expression of human hair keratin genes. Biology of the Cell 93(3-4): 233

Prieur, Marguerite; Lapierre, J.; Le Lorc'h, M.; Ozilou, C.; Amiel, J.; Sanlaville, D.; Vekemans, M.; Turleau, C.; Romana, S.P. 2000: HOXD gene cluster haploinsufficiency does not generate gross limb abnormalities. European Journal of Human Genetics 8(Suppl 1): 74

Perez Cabrera, A.; Zenteno, J.C.; Kofman Alfaro, S. 2001: HOXD13 gene analysis in subjects with complex digital anomalies. American Journal of Human Genetics 69(4 Suppl): 342

Go, M.F.; Li, L.; Frantz, J.; Neil, G.; Laine, L. 1999: HP cagA and vacA from US duodenal ulcer patients and association with eradication. Gut 45(Suppl 3): A108

Lacroix, M.; Gaudichon, C.; Huneau, J.F.; Villerette, E.; Bermond, A.; Tome, D. 2002: HP diet fed ad libitum reduces fattening in growing rats. FASEB Journal 16(5): A1023

Jonaitis, L.V.; Kiudelis, G.; Kupcinskas, L. 2001: HP eradication induces healing of gastritis, but not regression of atrophy and intestinal metaplasia during one-year follow-up in DU patients. IJMM International Journal of Medical Microbiology 291(Suppl 31): 56

Jonas, Claude; De Reuck, Marc; Otero, Julio; Denis, Patricia; De Koster, Erik; Deltenre, Michel 1999: HP eradication is not the end of the story A follow-up questionnaire. Gastroenterology 116(4 Part 2): A201

Catalano, F.; Catanzaro, R.; Giuseppe, B.; Bentivegna, C.; Cipolla, R.; Brogna, A. 1999: HP positive duodenal ulcer Three day antibiotic eradicating treatment. Gastroenterology 116(4 Part 2): A162

Godschalk, M.; Unice, K.; Bergner, D.; Ahmed, Q.; Sison, A.; Arulthirumaran, J.; Katz, P.G.; Mulligan, T.; Fatora, S.; Mcmichael, J. 1999: HP-4 as treatment for symptoms of BPH A placebo-controlled randomized study. Journal of the American Geriatrics Society 47(9): S70

Kellum, R. 2003: HP1 complexes and heterochromatin assembly. Current Topics in Microbiology and Immunology 274: 53-77

Terness, P.; Dufter, C.; Linke, S.; Kerek, F.; Jung, T.; Watzlik, A.; Opelz, G. 1999: HP12: a highly purified Helleborus species extract strongly potentiates the T-cell suppressive effect of cyclosporine a. Transplantation Proceedings 31(1-2): 1174-1175

Chuang, Y.; Yeh, Y.; Chang, K.; Lin, T.; Wang, J. 2002: HP1361 is essential for DNA transformation in Helicobacter pylori. Gut 51(Suppl 2): A11

Williams, K.L.; Ko, M.C.; Mukhopadhyay, P.; Ensley, A.J.; Fahmy, D.; Woods, J.H. 2001: HPA activation as a predictor of an opioid antagonists ability to reduce ethanol consumption. Alcoholism Clinical and Experimental Research 25(5 Suppl A): 24A

Levay, E.A.; Paolini, A.G.; Govic, A.; Hazi, A.; Penman, J.; Kent, S. 2010: HPA and sympathoadrenal activity of adult rats perinatally exposed to maternal mild calorie restriction. Behavioural Brain Research 208(1): 202-208

Dunn, A.J.; Ando, T.; Brown, R.F.; Berg, R.D. 2003: HPA axis activation and neurochemical responses to bacterial translocation from the gastrointestinal tract. Annals of the new York Academy of Sciences 992: 21-29

Schatzberg, A.F.; Flores, B.; Belanoff, J.; Solvason, B.; Keller, J.; Gomez, R. 2004: HPA axis activity, psychosis and cognition in major depression. Journal of Affective Disorders 78(Suppl 1): S51-S52

Pfennig, A.; Binder, E.B.; Kunzel, H.E.; Kern, N.; Fuchs, B.; Ising, M.; Muller Myhsok, B.; Modell, S.; Holsboer, F. 2003: HPA axis dysregulation and suicidal behavior in depression Differentiation of a genetically distinct subgroup?. American Journal of Medical Genetics 122B(1): 24

Rasmusson, A.M.; Lipschitz, D.S.; Wang, S.; Bremner, J.D.; Southwick, S.M.; Charney, D.S. 1999: HPA axis regulation in premenopausal women with PTSD. Society for Neuroscience Abstracts 25(1-2): 2066

Appelhans, B.M.; Pagoto, S.L.; Peters, E.N.; Spring, B.J. 2010: HPA axis response to stress predicts short-term snack intake in obese women. Appetite 54(1): 217-220

Miller, A. 2004: HPA axis responses and the development of cytokine-induced depression. Journal of Affective Disorders 78(Suppl 1): S52

Knapp, D.J.; Overstreet, D.H.; Moy, S.S.; Gause, L.R.; Clark, E.Jr; Breese, G.R. 1999: HPA axis responses differ in anxiety tests during acute versus protracted ethanol withdrawal. Alcoholism Clinical and Experimental Research 23(5 Suppl): 22A

Gura, T.; Roma, P.G.; Barr, C.; Becker, M.; Higley, S.B.; Suomi, S.J.; Higley, J.D. 2003: HPA axis responses of rhesus monkey mothers during separations vary from their first to second infants. American Journal of Primatology 60(Suppl 1): 105

Thrivikraman, K.V.; Ladd, C.O.; Plotsky, P.M. 1999: HPA axis responses to stressors modulated by feedback sensitive and resistant neurocircuitry. Society for Neuroscience Abstracts 25(1-2): 707

Krishnan Sarin, S.; George, T.P.; O'connor, P.G.; Farren, C.; Torello, R.; O'malley, S. 2003: HPA axis responsivity Differential changes produced by alcohol and/or nicotine dependence. Alcoholism Clinical and Experimental Research 27(5 Suppl): 165A

Adinoff, B.; Krebaum, S.; Chandler, P.; Velhuis, J.D.; Iranmanesh, A. 2003: HPA axis sensitivity in abstinent alcohol dependent subjects Isolation of axis pathology. Alcoholism Clinical and Experimental Research 27(5 Suppl): 165A

Sandman, C.A.; Touchette, P.E.; Marion, S.; Lenjavi, M. 2002: HPA disregulation is associated with contagious maladaptive behavior among neurodevelopmentally delayed individuals. Developmental Psychobiology 41(1): 93

Thies, A.; Moll, I.; Schumacher, U. 2000: HPA, but not PHA-L, SNA-I, WGA or MAA, is a prognostic marker in cutaneous malignant melanoma. Journal of Investigative Dermatology 115(3): 556

Castro, V.; Origa, A.F.; Carvalho, M.A.; Annichino Bizzacchi, J.M.; Soares, M.; Menezes, R.C.; Goncalves, M.S.; Costa, F.F.; Arruda, V.R. 1999: HPA-1 to 5 system frequencies in three distinct ethnic groups from Brazil. Transfusion 39(10 Suppl): 39S

Kastrati, A.; Koch, W.; Von Beckerath, N.; Kettling, C.; Elezi, S.; Seidl, H.; Gawaz, M.; Schoemig, A. 1999: HPA-3 polymorphism of the platelet fibrinogen receptor is not associated with an increased risk of thrombosis or restenosis after coronary stent placement. Journal of the American College of Cardiology 33(2 Suppl A): 41A-42A

Castro, V.; Alberto, F.L.; Costa, R.N.P.; Lepikson Neto, J.; Costa, D.S.P.; Saad, S.T.O.; Arruda, V.R.; Costa, F.F. 2002: HPA-5 Platelet Polymorphism A Risk Factor for Vascular Complications in Sickle Cell Anemia. Blood 100(11): Abstract No. 1746

Skouri, H.; Soua, H.; Seket, B.; Elomri, H.; Mounastiri, K.; Ayadi, A.; Gueddiche, M.N.; Sfar, M.T.; Bierling, P. 2003: HPA-5b neonatal allo-immune thrombocytopenia: two cases described in Tunisia. Archives de Pediatrie: Organe Officiel de la Societe Francaise de Pediatrie 10(10): 887-890

Irani, A.A.; Nayak, A.; Cruz Rivera, M.; Walton Bowen, K.; Smith, J.A. 1999: HPA-axis function in infants and young children with persistent asthma treated for 52 weeks with budesonide inhalation suspension. Journal of Allergy and Clinical Immunology 103(1 Part 2): S130-S131

Thwaites, D.T.; Ganapathy, V. 2003: HPAT1 A high capacity mechanism for taurine, betaine, imino acid and drug absorption across the human small intestine. Amino Acids 25(2): 132

Yokomizo, A.; Okumura, K.; Koga, H.; Akaza, H.; Tsukamoto, T.; Yoshihiko, H.; Naito, S. 2003: HPC/ELAC2 polymorphism associates with sporadic prostate cancer in Japan. Journal of Urology 169(4 Suppl): 49-50

Gerhard, D.S.; Suarez, B.K.; Nguyen, L.T.; Kesterson, N.K.; Lin, J.; Haberer, B.; Catalona, W.J. 2001: HPC2/ELAC2 is a marker for prostate cancer. European Journal of Human Genetics 9(Suppl 1): P0028

Schleutker, J.; Matikainen, M.; Baffoe Bonnie, A.; Xu, J.; Koivisto, P.; Tammela, T.; Smith, J.; Stephan, D.; Isaacs, W.B.; Trent, J.M.; Bailey Wilson, J.; Kallioniemi, O.P. 1999: HPCX linkage is common among Finnish prostate cancer families Strong association with late onset disease. American Journal of Human Genetics 65(4): A86

McCuaig,L.; Tinning,R. 2010: HPE and the moral governance of p/leisurable bodies. Sport, Education And Society: 1, 39-61

Liou, J.; Kiefer, F.; Weiss, A. 1999: HPK1 is a Ste20-related protein kinase that negatively regulates T-cell receptor-induced AP-1 activation. FASEB Journal 13(7): A1490

Stevenson, R. 2002: HPLC 02 Proteomics again dominates the HPLC series. American Biotechnology Laboratory 20(10): 4, 6, 8

Loeppky, R.N.; Shi, J. 2003: HPLC ES/API MS/MS identification and quantitation of adducts from the reaction of N-nitrosotolazoline with dA, dG, and DNA in vitro. Proceedings of the American Association for Cancer Research Annual Meeting 44: 391-392

Pedras, M.S.C.; Uppala, V.; Cekic, V. 2002: HPLC analyses of cultures of black-leg isolates from the Canadian prairies. Canadian Journal of Plant Pathology 24(1): 96

JungMeeJung; HeoSeongIl; WangMyeongHyeon 2010: HPLC analysis and antioxidant activity of Ulmus davidiana and some flavonoids. Food Chemistry 2010(1): 313-318

Squillace, D.P.; Ruben, S.L.; Reid, J.M.; Ames, M.M. 2000: HPLC analysis and murine pharmacokinetics of the cytotoxic bioreductive agent NLCQ-1. Proceedings of the American Association for Cancer Research Annual Meeting 41: 706

Yang, Q.; Wang, S.; Xie, Y.; Sun, J.; Wang, J. 2010: HPLC analysis of Ganoderma lucidum polysaccharides and its effect on antioxidant enzymes activity and Bax, Bcl-2 expression. International Journal of Biological Macromolecules 46(2): 167-172

Squina, F.M.; Mercadante, A.Z. 2003: HPLC analysis of carotenoids from five Rhodotorula strains. Revista Brasileira de Ciencias Farmaceuticas 39(3): 309-318

Gambino, A.S.; Jenkins, L.C.; Myers, J.; Stachowiak, M.K.; Corso, T.D. 2003: HPLC analysis of catacholamines and indolamines in brains of transgenic mice with a deletion mutation of the tyrosine kinase domain of the FGFR1 growth factor receptor. Abstracts of Papers American Chemical Society 225(1-2): CHED 900

Sanchez, D.; Smith, C.A. 2002: HPLC analysis of catecholamine extracts from the banana peel. Abstracts of Papers American Chemical Society 223(1-2): CHED 233

Durham, D.G.; Lee, A.; Low, A.S. 1999: HPLC analysis of chiral benzodiazepines using heptakis- -beta-cyclodextrin in the mobile phase. Journal of Pharmacy and Pharmacology 51(Suppl ): 74

Li, W.; Fitzloff, J.F. 2002: HPLC analysis of ginsenosides in the roots of Asian ginseng and North American ginseng with in-line photodiode array and evaporative light scattering detection. Journal of Liquid Chromatography and Related Technologies 25(1): 29-41

Sharma, P.; Chawla, H.P.S.; Panchagnula, R. 2000: HPLC analysis of lovastatin and cyclosporin in Krebs-Ringer bicarbonate solution in in-vitro everted rat intestinal sac model. Journal of Pharmacy and Pharmacology 52(Suppl): 76

Daeschel, M.A.; Musafija Jeknic, T.; Wu, Y.; Bizzarri, D.; Villa, A. 1999: HPLC analysis of lysozyme in wine. American Journal of Enology and Viticulture 50(3): 373

Conwell, D.L.; Mullick, T.; Heyrman, A.; Zuccaro, G.; O'laughlin, C.; Tasch, J. 2002: HPLC analysis of pancreatic fluid differentiates chronic pancreatitis from normal volunteers. Gastroenterology 122(4 Suppl 1): A-510

Ramenskaya, G.V. 2003: HPLC analysis of plasma verapamil and its metabolite. Farmatsiya (Moscow) (2): 38-39

Theodoridis, G.; Laskaris, G.; Verpoorte, R. 1999: HPLC analysis of taxoids in plant and plant cell tissue cultures. American Biotechnology Laboratory 17(9): 40;42;44

Bolterman, S.A.; Reid, J.M.; Jia, L.; Shami, P.J.; Ames, M.M. 2003: HPLC analysis of the NO-donating prodrug JS-K Inhibition of sulfhydryl-catalyzed degradation in plasma and whole blood lysates by thiol depletion with diamide. Proceedings of the American Association for Cancer Research Annual Meeting 44: 334

Baj, T.; Wolski, T. 2000: HPLC analysis of the content of phenolic acids occurring in two varieties of dittany. Phytomedicine 7(Suppl 2): 74

Sierra Santoyo, A.; Barton, H.A.; Hughes, M.F. 2003: HPLC analysis of vinclozolin and its metabolites in serum. Toxicological Sciences 72(S-1): 91

Akamatsu, K.; Fujii, K.; Yokoya, A. 2003: HPLC and EPR analysis of thymine derivatives produced by ultrasoft X- and 60Co gamma-irradiation. Journal of Radiation Research 44(4): 433

Dolnikowski, G.G.; Sun, Z.; Grusak, M.A.; Peterson, J.W.; Booth, S.L. 2001: HPLC and GC/MS determination of deuterated vitamin K in human serum after ingestion of deuterium labeled broccoli. FASEB Journal 15(5): A959

Escoubas, P.; Corzo, G.; Whiteley, B.J.; Celerier, M.L.; Nakajima, T. 2001: HPLC and MALDI-TOF-MS study of quantitative and qualitative variation in tarantula spider venoms. Toxicon 39(2-3): 157-158

Yeh, G.C.; Gaut, J.P.; Byun, J.; Heinecke, J.W. 2001: HPLC and MS analysis of enzymatically-produced halogenated amino acids Implications for biochemical pathways of phagocyte-mediated tissue injury. Abstracts of Papers American Chemical Society 221(1-2): ANYL 78

Frenz, J. 2003: HPLC and the biotechnology industry. Abstracts of Papers American Chemical Society 225(1-2): ANYL 241

AiGuoMin; ZouDongYun; ShiXueYan; LiFuGen; LiangPei; SongDunLun; Xiwu 2010: HPLC assay for characterizing alpha -cyano-3-phenoxybenzyl pyrethroids hydrolytic metabolism by Helicoverpa armigera based on the quantitative analysis of 3-phenoxybenzoic acid. Journal of Agricultural and Food Chemistry 2: 694-701

Grazia Alessandrì, M.; Celati, L.; Battini, R.; Baldinotti, F.; Item, C.; Leuzzi, V.; Cioni, G. 2004: HPLC assay for guanidinoacetate methyltransferase. Analytical Biochemistry 331(1): 189-191

Hagemeier, R.; Maier, K.; Klum, R.; Henderson, L.; Skelton, M.M.; Cowley, A.W.Jr; Roman, R.J. 2002: HPLC assay for the measurement of biopterin levels An index of oxidative stress. FASEB Journal 16(4): A429

Chaves Das Neves, Higuinaldo, J. 1999: HPLC assay of amino acids and oligopeptides. American Biotechnology Laboratory 17(10): 54-55

Garza, P.; Zewail Foote, M. 2003: HPLC assay to quantify abasic sites on DNA. Abstracts of Papers American Chemical Society 225(1-2): CHED 836

Sbrissa, D.; Ikonomov, O.; Shisheva, A. 1999: HPLC characterization of the in vitro lipid products generated by the adipocytic p235 Effect of insulin. Diabetes 48(Suppl 1): A226-A227

Chaimbault, P.; Elfakir, C.; Lafosse, M.; Blanchard, F.; Marc, I. 1999: HPLC control of an alkyl glycoside synthesis. HRC Journal of High Resolution Chromatography 22(3): 188-190

Huo, Y.; Shi, H.; Li, W.; Wang, M.; Li, X. 2010: HPLC determination and NMR structural elucidation of sesquiterpene lactones in Inula helenium. Journal of Pharmaceutical and Biomedical Analysis 51(4): 942-946

Ichikawa, M.; Udayama, M.; Imamura, K.; Shiraishi, S.; Matsuura, H. 2003: HPLC determination of (+)-pseudoephedrine and (-)-ephedrine in Japanese herbal medicines containing Ephedra herb using solid-phase extraction. Chemical and Pharmaceutical Bulletin 51(6): 635-639

Obreshkova, D.; Pangarova, T.; Lazarova, V. 2000: HPLC determination of Galanthamine and related alkaloids in Nivalin. Dokladi na B"lgarskata Akademiya na Naukite 53(9): 51-52

Castellana, C.N.; Gallesi, D.; Poppi, B.; Trenti, T. 1999: HPLC determination of amphetamine analogues methylenedioxyamphetamine and 3,4 methylenedioxymethamphetamine. Clinical Chemistry and Laboratory Medicine 37(SPEC Suppl ): S319

Sladkovský, R.; Solich, P.; Opletal, L. 2000: HPLC determination of caffeine in a multicomponent preparation. Die Pharmazie 55(6): 464-465

Yang Chang Jin; Qian Wei; Liang Ling Zhi 1999: HPLC determination of captopril tablets using electro-chemical detector. Zhongguo Yiyao Gongye Zazhi 30(3): 136-138

H.M.ng Yang; Zhou Xing Qin; Yang Ming 1999: HPLC determination of contrast MIBI. Zhongguo Yiyao Gongye Zazhi 30(10): 464

Liu Yan Ping; Gao, L.L. 2000: HPLC determination of dissolution of isosorbide-5-mononitrate capsules. Zhongguo Yiyao Gongye Zazhi 31(3): 132-133

Wang Jing Xiang; Wang, J.K.i 1999: HPLC determination of fleroxocin and its tablets. Zhongguo Yiyao Gongye Zazhi 30(5): 226-227

Schepky, A.; Siegner, R.; Diembeck, W. 1999: HPLC determination of metabolites of the inflammatory key enzymes using a diode-array-UV-detector and a light-scattering-detector in series. Journal of Investigative Dermatology 112(4): 600

Bidnychenko, Y.ri 2000: HPLC determination of mushroom peptide toxins in forensic-chemical examination. American Laboratory 32(9): 14

Cao Hai 1999: HPLC determination of ofloxacin glucose injection. Zhongguo Yiyao Gongye Zazhi 29(12): 560-561

Wu, F.; He, Z.; Luo, Q.; Zeng, Y.'e 1999: HPLC determination of oxalic acid using tris ruthenium chemiluminescence-Application to the analysis of spinach. Food Chemistry 65(4): 543-546

Bovanova, L'.; Brandsteterova, E.; Caniova, A.; Argalasova, K.; Lux, A. 1999: HPLC determination of peroxisomicine A1 in Karwinskia fruits Comparison of off-line solid phase extraction and columns switching heart-cut sample preparation. Pharmazie 54(12): 941-942

Nakashima, K.; Kinoshita, S.; Wada, M.; Kuroda, N.; Baeyens, W.R.G. 1999: HPLC determination of phenols in human urine with 4- benzoyl chloride as a fluorescent label. Biomedical Chromatography 13(2): 139-140

Anonymous 2004: HPLC determination of polyphenols in dry grape stem extract. Khimiko-Farmatsevticheskii Zhurnal. 38(3): 26-28

Li, J.Y.; Li, J.S.; Xu, Z.Z.; Lu, R.H. 2003: HPLC determination of quinocetone in edible chicken tissues. Toxicology 191(1): 55, September 15th

Mirkovic, D.; Jovic, N.; Majkic Singh, N.; Milovanovic, D. 1999: HPLC determination of serotonin in children treated with lamotrigine. Clinical Chemistry and Laboratory Medicine 37(SPEC Suppl ): S347

Kondratenko, S.N.; Starodubtsev, A.K.; Belyakova, G.A.; Serebrova, S.Y.; Pichugin, A.V. 2002: HPLC determination of the pharmacokinetics and relative bioavailability of Omeprazole-Akri. Khimiko-Farmatsevticheskii Zhurnal 36(10): 49-50

ChenBingLuan; ZhouYiFeng; ChenBaoEr; HangYueYu 2010: HPLC fingerprint chromatogram of rhizoma dioscoreae hypoglaueae medicinal materials. Acta Botanica Boreali Occidentalia Sinica: 1, 156-162

Wehner, T.A.; Morneweck, L.A.; Hicks, M.B.; Payne, L.D. 2000: HPLC fluorescence method to determine residues of emamectin benzoate and its metabolites on vegetables. Abstracts of Papers American Chemical Society 220(Part 1): AGRO 8

Flicker, T.M.; Green, S.A. 1999: HPLC for the comparison of free-radical populations in model postcombustion systems. Abstracts of Papers American Chemical Society 218(1-2): ANYL 61

Cody, C.W.; Hutchison, J.S.; Guthrie, E.; Lu, J.; Miller, P.; Caulfield, M.; Reitz, R.E. 2001: HPLC fractionation and detection of PTH fragments in patient samples using two new automated assays measuring PTH 1-84 and PTH 1-38. Journal of Bone and Mineral Research 16(Suppl 1): S426

Kulevanova, S.; Stefova, M.; Stafilov, T. 2000: HPLC identification and determination of flavone aglycones in Helichrysum plicatum DC. Pharmazie 55(5): 391-392

Horgan, E.D.; Rahman, I.A.; Vasikaran, S.D. 2000: HPLC measurement of pamidronate in urine. Bone (New York) 27(4 Suppl): 42S

Skalicky, J.; Kandar, R.; Cegan, A.; Muzakova, V.; Zuber, R. 1999: HPLC method for determination of allantoin in human plasma. Clinical Chemistry and Laboratory Medicine 37(SPEC Suppl ): S359

Mccoy, L.F.; Schleicher, R.L.; Pfeiffer, C.M. 2003: HPLC method for measurement of ascorbic acid in serum using electrochemical detection with an internal standard. Clinical Chemistry 49(S6): A144

Schleicher, R.L.; Courts, S.A.; Sowell, A.L.; Gunter, E.W.; Miller, D.T. 1999: HPLC method for simultaneous quantitation of lutein, zeaxanthin, beta-cryptoxanthin, alpha- and beta-carotenes, lycopene, retinol, retinyl stearate and palmitate, and alpha- and gamma-tocopherols in serum. FASEB Journal 13(4 Part 1): A239

Carducci, C.; Birarelli, M.; Leuzzi, V.; Carducci, C.; Antonozzi, I. 2000: HPLC method for the determination of guanidino compounds in biological liquids and dried blood spot. Journal of Inherited Metabolic Disease 23(Suppl 1): 274

Ogawa, S.; Yoshidomi, T.; Shirabe, T.; Yoshimura, E. 2010: HPLC method for the determination of phytochelatin synthase activity specific for soft metal ion chelators. Journal of Inorganic Biochemistry 104(4): 442-445

Gearhart, L.A.; Garcia, J.M.; Woodeshick, R.W.; Segretario, J.; Hovsepian, P.K. 2000: HPLC method validation for assay and degradation products of efavirenz oral solution. Abstracts of Papers American Chemical Society 220(Part 1): ANYL 77

Kaddoumi, A.; Nakashima, M.N.; Wada, M.; Kuroda, N.; Nakahara, Y.; Nakashima, K. 2001: HPLC of -fenfluramine and phentermine in plasma after derivatization with dansyl chloride. Journal of Liquid Chromatography and Related Technologies 24(1): 57-67

Andreeva, T.V.; Kuznetsova, E.E.; Gorokhova, V.G.; Gorokhov, A.G. 2000: HPLC of antipyrine as a method for rapid diagnosis of the functional activity of human liver monooxygenase. Khimiko-Farmatsevticheskii Zhurnal 34(1): 10-11

Kirkland, J.J.; Martosella, J.D.; Henderson, J.W.; Dilks, C.H.Jr.; Adams, J.B.Jr 1999: HPLC of basic compounds at high pH with a silica-based bidentate-C18 bonded-phase column. American Laboratory 31(22): 22-27

Oshitani, N.; Hato, F.; Sogawa, M.; IImuro, M.; Yamagami, H.; Jinno, Y.; Sawa, Y.; Hara, J.; Nakamura, S.; Matsumoto, T.; Kitagawa, S.; Arakawa, T. 2000: HPLC profiles of human class II MHC-binding peptides obtained from intestine. Gastroenterology 118(4 Suppl 2 Pt 2): AGA A1362

Slater, J.B.; Gunn, J.W.; Assaad, P.S. 2000: HPLC protocols for routine Tc radiopharmaceutical quality control. Journal of Nuclear Medicine 41(5 Suppl): 249P

Arakawa, K.; Kawai, Y.; Ito, Y.; Nakamura, K.; Chujo, T.; Nishimura, J.; Kitazawa, H.; Saito, T. 2010: HPLC purification and re-evaluation of chemical identity of two circular bacteriocins, gassericin A and reutericin 6. Letters in Applied Microbiology 50(4): 406-411

Ponchant, M.; Dolle, F.; Bramoulle, Y.; Demphel, S.; Fournier, D.; Hinnen, F.; Gervais, P.; Crouzel, C. 2001: HPLC purity control of PET radiopharmaceuticals in a GMP quality-control laboratory. Journal of Labelled Compounds and Radiopharmaceuticals 44(Suppl 1): S823-S825

Wang, W.D.; To, C.; Li, F.; Nguyen, A. 2000: HPLC quantitation of trace vitamins in complex multi-vitamin, mineral, and herbal formulas. Abstracts of Papers American Chemical Society 220(Part 1): AGFD 152

Dudones, L.P.; Bose, R.N. 1999: HPLC separation and characterization of cis-platin-DNA fragments in the presence of biological thiols. Abstracts of Papers American Chemical Society 217(1-2): ANYL 52

Stefan Bodea, C.M.; Verjee, Z. 2003: HPLC separation of azathioprine and 6-mercaptopurine metabolites in blood Improved quality and cost-effectiveness. Clinical Chemistry 49(S6): A124

Peter, A.; Torok, G.; Vekes, E.; Van Betsbrugge, J.; Tourwe, D. 2004: HPLC separation of enantiomers of alpha-substituted proline analogues by the application of -N- phenylalanine methoxyethyl ester as chiral derivatizing agent. Journal of Liquid Chromatography and Related Technologies 27(1): 17-29

Larsen, R.A.; Jenkins, A.L. 2003: HPLC separations using Circular Dichroism and fluorescence detection. Abstracts of Papers American Chemical Society 226(1-2): BIOL 196

Ouchemoukh,S.; Schweitzer,P.; Bey,M.B.; Djoudad-Kadji,H.; Louaileche,H. 2010: HPLC sugar profiles of Algerian honeys. Food Chemistry 1(2): 561-568

Ferguson, P.L.; Benotti, M.J.; Heine, C.E.; Brownawell, B.J. 2002: HPLC time-of-flight mass spectrometry An alternative to LC-MS-MS for sensitive and selective determination of polar organic contaminants in the aquatic environment. Abstracts of Papers American Chemical Society 223(1-2): ENVR 5

Kompantseva, E.V.; Gavrilin, M.V.; Minastireva, I.I. 1999: HPLC use for determination of strange admixtures in diprazin. Farmatsiya 48(1): 26

Boyer, G.L. 2001: HPLC with electrochemical oxidation for the analysis of PSP toxins Is it time for another interlaboratory trial?. Canadian Technical Report of Fisheries and Aquatic Sciences 2386: 105

Li, W.; Fitzloff, J.F. 2002: HPLC with evaporative light scattering detection as a tool to distinguish Asian ginseng and North American ginseng. Journal of Liquid Chromatography and Related Technologies 25(1): 17-27

Krol, J.; Block, E.; Young, M.; Benvenuti, M.; Yonekubo, J.; Romano, J. 2000: HPLC with mass spectrometry detection for the analysis of endocrine disruptors. Abstracts of Papers American Chemical Society 219(1-2): ENVR 22

Ramos-Escudero,F.; Santos-Buelga,C.; Perez-Alonso,J.J.; Yanez,J.A.; Duenas,M. 2010: HPLC-DAD-ESI/MS identification of anthocyanins in Dioscorea trifida L yam tubers. European Food Research And Technology 2010(5): 745-752

Krachler, M.; Falk, K.; Emons, H. 2002: HPLC-HG-AAS and HPLC-ICP-MS for speciation of arsenic and antimony in biomonitoring. American Laboratory 34(6): 10, 12, 14

Herderich, M. 2000: HPLC-MS analysis of carotenoid-derived aroma precursors. Abstracts of Papers American Chemical Society 219(1-2): AGFD 64

Liu, Y.M.; Prasad, C. 2003: HPLC-MS-MS of enterostatin in human CSF and plasma. Abstracts of Papers American Chemical Society 225(1-2): ANYL 63

Wilson, I.D. 2000: HPLC-NMR-MS studies in drug metabolism. Drug Metabolism Reviews 32(Suppl 1): 2

Xie, S.Y.; Peng, Y.; Chen, M.; Huang, R.B.; Zheng, L.S. 2003: HPLC-UV-MS separation and identification of chlorinated polycyclic aromatic hydrocarbons. Abstracts of Papers American Chemical Society 225(1-2): ANYL 68

Liebes, L.; Conaway, C.C.; Mendoza, S.; Hecht, S.S.; Chung, F.L. 2000: HPLC-based method for measuring total isothiocyanates in human plasma. Proceedings of the American Association for Cancer Research Annual Meeting 41: 659

Corran, P.H.; Ekong, T.A.N.; Gee, C.; Sesardic, D. 1999: HPLC-based methods for the measurement of clostridial neurotoxin proteolytic activity. Brown, Fred Author, Hendriksen, Coenraad F M Author, Sesardic, Dorothea Author Developments in Biological Standardization Alternatives to animals in the development and control of biological products for human and veterinary use : 314

Hammerstone, J.F.; Lazarus, S.A.; Adamson, G.E. 1999: HPLC/MS analysis of flavonoids in foods and beverages. Abstracts of Papers American Chemical Society 217(1-2): AGFD 037

Needham, S.R.; Ye, B. 2003: HPLC/MS/MS method for the analysis of the glycopeptide, vancomycin from plasma Developing methods when typical methods are unsuccessful. Drug Metabolism Reviews 35(Suppl 2): 80

Needham, S.; Ye, B.; Smith, J.R.; Capacio, B.R. 2003: HPLC/MS/MS quantitative bioanalysis of the anti-chemical warfare agent drug atropine from monkey serum using a novel extraction method. Drug Metabolism Reviews 35(Suppl 2): 81

Lewis, R.J.; Jones, A.; Vernoux, J.P.ul 1999: HPLC/mass spectrometry and HPLC/MS/MS methods for the detection of multiple ciguatoxins. Seret, B, Sire, J -Y 5th Indo-Pacific Fish Conference 739-744

Malugin, A.; Kopeckova, P.; Kopecek, J. 2003: HPMA copolymer-bound doxorubicin induces apoptosis in human ovarian cancer cells by a Fas independent pathway. Journal of Controlled Release 91(1-2): 254, 28 August

Ulbrich, K.; Etrych, T.; Chytil, P.; Jelínková, M.; Ríhová, B. 2003: HPMA copolymers with pH-controlled release of doxorubicin: in vitro cytotoxicity and in vivo antitumor activity. Journal of Controlled Release: Official Journal of the Controlled Release Society 87(1-3): 33-47

Tseng, L.; Mazella, J. 2001: HPRA is a strong inducer for the production prolactin in endometrial stromal cells. Biology of Reproduction 64(Suppl 1): 262

Shanmugam, N.; Xu, L.; Augustus, M.; Moul, J.; Srivastava, S.; Florence, K.; Soppet, D.; Sesterhenn, I.A.; Mcleod, D.G.; Stackhouse, G.B.; Carter, K. 2000: HPRAJ, a novel prostate specific gene with homology to olfactory receptor gene family is over-expressed in prostate cancer. Journal of Urology 163(4 Suppl): 38

Heflich, R.H.; Mittelstaedt, R.A.; Shaddock, J.G.; Von Tungein, L.S.; Bendre, S.V.; Beland, F.A.; Dobrovolsky, V.N. 2003: HPRT and TK in model systems. Environmental and Molecular Mutagenesis 41(3): 220

Zhang, L.F.; Xi, L.; Bigbee, W.L.; Day, R.D.; Ness, R.B.; Keohavong, P. 2000: HPRT gene alterations in umbilical cord blood T-lymphocytes in newborns of smoking mothers. Proceedings of the American Association for Cancer Research Annual Meeting 41: 436

O'neill, J.P.; Gundel, R.M.; Trombley, L.M.; Walker, V.E. 2001: HPRT mutant frequency and mutation spectrum in newborns with perinatal exposure to antiviral drugs. Environmental and Molecular Mutagenesis 37(Suppl 32): 58

Albertini, R.J.; Jacobson Kram, D.; Sullivan, L.M.; Gucer, P.; Mcdiarmid, M.A. 2003: HPRT mutations in T-cells in Gulf War veterans exposed to depleted uranium. Toxicological Sciences 72(S-1): 280

Galvin, R.J.S.; Fuson, T.R.; Yang, X.; Harvey, A.K.; Chandrasekhar, S. 2001: HPTH stimulation of bone resorption in murine calvariae is mediated in part by its ability to decrease OPG secretion. Journal of Bone and Mineral Research 16(Suppl 1): S449

Allen, C.M.; Chakravarthy, B.; Morley, P.; Whitfield, J.F.; Willick, G.E. 2002: HPTH- and hPTH- NH2 prevent phosphate from killing MC3T3-E1 preosteoblasts and HKRKB7 pig kidney cells. Journal of Bone and Mineral Research 17(Suppl 1): S390

Muller, E.E.; Fried, B.; Sherma, J. 2000: HPTLC analysis of neutral lipids in Biomphalaria glabrata snails infected with Schistosoma mansoni. Journal of Planar Chromatography - Modern TLC 13(3): 228-231

Jamshidi, A.; Shahmiri, S.; Adjvadi, M. 2000: HPTLC assay for aspirin and free salicylic acid in newly formulated liquorice-containing tablets. Journal of Planar Chromatography - Modern TLC 13(5): 382-384

Peneva, B.; Krasteva, I.; Nikolov, S.; Minkov, E. 2000: HPTLC densitometric determination of ruscogenins in dry extract of Ruscus aculeatus L. Die Pharmazie 55(7): 541-542

Sane, R.T.; Menezes, A.; Mote, M.; Moghe, A.; Gundi, G. 2004: HPTLC determination of montelukast sodium in bulk drug and in pharmaceutical preparations. Journal of Planar Chromatography - Modern TLC 17(1): 75-78

Muller, E.E.; Fried, B.; Sherma, J. 1999: HPTLC determination of neutral lipids and phospholipids in snail conditioned water from Lymnaea elodes. Journal of Planar Chromatography - Modern TLC 12(2): 155-158

Muller, E.E.; Fried, B.; Sherma, J. 1999: HPTLC determination of neutral lipids in the cercariae of Echinostoma trivolvis and Echinoparyphium sp. Journal of Planar Chromatography - Modern TLC 12(4): 306-308

Vasudevan, T.N.; Kulkarni, V.P. 2000: HPTLC determination of tryptophanase. Journal of Pharmaceutical and Biomedical Analysis 22(4): 711-715

Salvi, S.A.; Uchil, D.A.; Rege, N.N.; Deshmukh, K.V.; Dahanukar, S.A. 2001: HPTLC fingerprinting A tool for authentication and dosage adjustment of plant drug. Indian Journal of Pharmacology 33(2): 134

Devi, K.S.; Sastry, G.S.R. 2002: HPTLC method for the determination of sanguinarine in argemone and in argemone-adulterated edible oils. Journal of Planar Chromatography - Modern TLC 15(3): 223-225

Duerksen Hughes, P.; Filippova, M. 2001: HPV 16 E6 binds to TRADD and blocks activation of the downstream apoptotic pathway. Journal of Leukocyte Biology Suppl: 71

Duerksen Hughes, P.J.; Filippova, M.; Parkhurst, L. 2003: HPV 16 E6 protects cells from tumor necrosis factor- and Fas-induced apoptosis by binding to tumor necrosis factor receptor 1 and to Fas-associated death domain. Proceedings of the American Association for Cancer Research Annual Meeting 44: 590

Wells, M.; Boon, A.P.; Lane, G.; Crompton, A.C.; Berthier, E.; Stewart, R.; Keeling, K.; Wells, J.T.; Cross, S.S. 1999: HPV 16 status and urinary cotinine levels in the progression of cervical intraepithelial neoplasia in women with mildly dyskaryotic smears. Journal of Pathology 189(Suppl): 5A

Meyer, T.; Arndt, R.; Beckmann, E.R.; Christophers, E.; Stockfleth, E. 2000: HPV 53 and HPV 73 Low-risk or high-risk HPV types?. Infection 28(Suppl 1): 50-51

Darsky, E.; Heirler, F. 2000: HPV DNA in plasma A new prognostic/diagnostic marker. Tumor Biology 21(Suppl 1): 48

Richart, R.M. 2002: HPV DNA testing for primary screening for cervical neoplasia. Acta Cytologica 46(1 Suppl): 218

Kumar, A.; Gao, Q.; Singh, L.; Srinivasan, S.; Wazer, D.E.; Band, V. 2002: HPV E6 induced degradation of E6TP1 is mediated by E6AP ubiquitin ligase. Proceedings of the American Association for Cancer Research Annual Meeting 43: 150

Papillo, J.L.; Riley, E.R.; Giroux, S.N.; Mount, S.L.; Cooper, K. 2000: HPV Educating adolescents. Acta Cytologica 44(5): 870

Ramael, M.; Van Steelandt, H. 1999: HPV and HHV-8 DNA in low grade and high grade squamous intraepithelial lesions of the uterine cervix. Virchows Archiv 435(3): 295

Gulbahce, H.E.; Johari, V.P.; Savik, K.; Mcglennen, R.C.; Mckeon, D.; Lundeen, S.J.; Pambuccian, S.E. 2003: HPV and biopsy correlates of ASCUS re-classified as ASC-US and ASC-H according to the 2001 Bethesda system. Modern Pathology 16(1): 66A-67A

Xavier Bosch, F. 2002: HPV and cervical adenocarcinoma Implications for screening programs. Acta Cytologica 46(1 Suppl): 97-98

Hagmar, B.; Dillner, J.; Wadell, G.; Strand, A.; Hansson, B.G.; Forslund, O.; Antonsson, A.; Ryd, W.; Rylander, E. 2002: HPV and progression-related molecular factors in cervical carcinoma. Acta Cytologica 46(1 Suppl): 131

Kaufmann, A.M.; Schneider, A. 1999: HPV as target for immunotherapy of cervical cancer. European Journal of Cancer 35(Suppl 5): S8

Lloveras, B.; Ponce, J.; Albadalejo, D.; Abarca, N.; Catala, I.; Ferrer, J.E. 1999: HPV detection using Hybrid Capture II in patients referred to a cervical pathology unit. Virchows Archiv 435(3): 211

Meyer, J.; Felix, J.; Naidu, Y.; Lentrichia, B. 2001: HPV genotypes in southern California HPV type differentiation requirements for triage of ASCUS Pap specimens. Laboratory Investigation 81(1): 57A

Petry, K.U. 2001: HPV in gynecology Association with CIN and cervical cancer. International Journal of STD and AIDS 12(Suppl 2): 18

Pinto, P.A.; Mellinger, B.C. 1999: HPV in the male patient. Urologic Clinics of North America 26(4): 797-807 Ix

Schneede, P.; Frimberger, D. 2001: HPV in warts, intraepithelial neoplasia and invasive cancer of the urethra. International Journal of STD and AIDS 12(Suppl 2): 19

Norrild, B. 2002: HPV infection New aspects. International Journal of Cancer Suppl (13): 44-45

Harlozinska, A.; Bar, J.; Sedlaczek, P.; Kasiak, J.; Markowska, J. 2000: HPV infection and P53, ERBB-2 and Ki-67 expression in cervical carcinomas and dysplasias. Tumor Biology 21(Suppl 1): 146

Huang, H.Y.; Liu, K.L.; Suen, J.Y.; Hanna, E.; Fan, C.Y. 2002: HPV infection and p53 gene overexpression in tonsilar squamous cell carcinomas and uvular papillomas. Laboratory Investigation 82(1): 219A-220A

Bossi, P.; Squadrelli, M.; Oggionni, M.; Suardi, S.; Locati, L.D.; Biffi, A.; Rinaldi, G.; Licitra, L.; Cantu, G.; Pilotti, S. 2003: HPV infection as prognostic factor in squamous cell cancers of oropharynx treated with surgery with or without radiotherapy. EJC Suppls 1(5): S204-S205

Migliora, P.; Zappatore, R.; Cesari, S.; Vesentini, N.; Spinillo, A.; Di Roma, A.M.; Carnevali, L.; Tenti, P. 1999: HPV latent infection in a vaginitis clinic cohort. Modern Pathology 12(1): 153A

Thunnissen, F.B.; Prinsen, C.; De Valk, H.; Horrevorts, A.; Klaassen, C. 2003: HPV microarray analysis of archival material. Modern Pathology 16(1): 327A-328A

Gu, X.; Schwartz, J.L.; Regezi, J.; Silvermen, S. 2000: HPV serotyping, mutations in p53, and markers for apoptosis expressed in serial biopsies of premalignant and malignant verrucous lesions. Proceedings of the American Association for Cancer Research Annual Meeting 41: 688

Hameed, M.; Fernandes, H.; Moore, D.; Kloser, D.; Heller, D. 2000: HPV subtyping in HIV-positive women. Laboratory Investigation 80(3): 125A

Carozzi, F.; Confortini, M.; Cecchini, S.; Ciatto, S. 2001: HPV testing for cervical neoplasia. Acta Cytologica 45(4): 659-661

Tranovich, V.; Balliett, C.; Keyhani Rofagha, S. 1999: HPV testing improves the sensitivity of detecting HGSIL. Modern Pathology 12(1): 52A

Keyhani Rofagha, S.; Tranovich, V.; Balliett, C. 2002: HPV testing improves the sensitivity of detecting HSIL. Acta Cytologica 46(1 Suppl): 152

Dillner, J. 2002: HPV testing in cervical cancer. International Journal of Cancer Suppl (13): 31-32

Delvenne, P.; Giannini, S.L.; Havard, L.; Hubert, P.; Jacobs, N.; Renard, I.; Boniver, J. 2002: HPV vaccination and new immunotherapeutic approaches to cervical neoplastic lesions. Acta Cytologica 46(1 Suppl): 112

Lee, B.N.; Tortolero, G.; Helfgott, A.; Eriksen, N.; Rebel, K.; Mitchell, M.F.; Reuben, J.M. 1999: HPV viral load measured by the DNA hybrid capture assay is predictive of the clinical stage of cervical disease in immune compromised women. Proceedings of the American Association for Cancer Research Annual Meeting 40: 43

Jappe, U.; Mueller, M.; De Villiers, E.M.; Roussaki, A.; Gross, G. 2002: HPV-11-L1-antibodies and HPV-DNA in children with anogenital warts and in their close contact persons. International Journal of STD and AIDS 13(Suppl 1): 27

Majorova, E.; Boor, A.; Jurkovic, I.; Dudrikova, K.; Krajcar, R.; Kocan, P.; Rimarova, K. 2000: HPV-like changes in the oesophageal squamous epithelium in children with reflux esophagitis. JPGN 31(Suppl 2): S101

Roberts, P.C.; Frank, B.L.; Szymkowski, D.E.; Mills, J.S.; Goodchild, J.; Wolfe, J.L.; Kilkuskie, R.E.; Greenfield, I.M.; Sullivan, V. 2002: HPV-specific oligonucleotides. Official Gazette of the United States Patent and Trademark Office Patents 1263(1)

Menton, M.; Menton, S.; Iftner, T.; Wallwiener, D. 2003: HPV-test=Knock-out for cytological screening?. Pathology Research and Practice 199(4): 258

Youde, S.J.; Dunbar, P.R.; Evans, E.M.L.; Fiander, A.N.; Borysiewicz, L.K.; Cerundolo, V.; Man, S. 1999: HPV16 E7 peptide tetramers isolate rare human CTL recognising endogenous HPV antigens. Immunology 98(Suppl 1): 21

Thorland, E.C.; Myers, S.; Smith, D.I. 2001: HPV16 integrations in cervical tumors exhibit specificity for common fragile sites, cluster at specific chromosomal regions, and may disrupt genes important in cervical carcinogenesis. Proceedings of the American Association for Cancer Research Annual Meeting 42: 114

Thorland, E.C.; Myers, S.L.; Gostout, B.S.; Smith, D.I. 2000: HPV16 integrations in cervical tumors preferentially occur within the common fragile sites and cluster at specific sites. American Journal of Human Genetics 67(4 Suppl 2): 79

Thorland, E.C.; Myers, S.; Persing, D.; Smith, D.I. 1999: HPV16 preferentially integrates into the common fragile sites in cervical cancer. American Journal of Human Genetics 65(4): A11

D.O., A.P.; Goncalves, T. 2003: HPV16-E6 expression in Saccharomyces cerevisiae Interaction with intrinsic proteins that alter normal cell functioning. Yeast 20(Suppl 1): S177

Ferber, M.J.; Gostout, B.S.; Smith, D.I. 2003: HPV18 integrations near c-myc are associated with aggressive cervical cancers. Proceedings of the American Association for Cancer Research Annual Meeting 44: 1024

Ferber, M.J.; Wu, W.F.; Brink, A.; Thorland, E.; Smith, D.I. 2002: HPV18 preferentially integrates at or near c-myc in HPV18-positive cervical tumors. American Journal of Human Genetics 71(4 Suppl): 230

Rosenthal, D.W.; Devoti, J.A.; Steinberg, B.M.; Bonagura, V.R. 2004: HPV6 up-regulates cyclooxygenase-2 in recurrent respiratory papillomatosis. Journal of Allergy and Clinical Immunology 113(2 Suppl): S213

Merlin, Didier; Si Tahar, Mustapha; Sitaraman, Shanthi V.; Eastburn, Karen; Williams, Ifor; Hediger, Matthias; Madara, James L. 2001: HPepT1 expression occurs in chronic colitis and related transport of bacterial peptides influences expression of class 1 molecules. Gastroenterology 120(5 Suppl 1): A 697

Incandela, L.; Belcaro, G.; Renton, S.; Desanctis, M.T.; Cesarone, M.R.; Bavera, P.; Ippolito, E.; Bucci, M.; Griffin, M.; Geroulakos, G.; Dugall, M.; Golden, G.; Acerbi, G. 2002: HR -rutosides in venous hypertensive microangiopathy A prospective, placebo-controlled, randomized trial. Journal of Cardiovascular Pharmacology and Therapeutics 7(Suppl 1): S7-S10

Oh, C.S.; Kim, W.S.; Beer, S.V. 2002: HR induction in tobacco by Erwinia amylovora requires DspE in addition to a harpin. Phytopathology 92(6 Suppl): S60

Nissinen, R.M.; Beer, S.V.; Metzler, M.C. 1999: HR-elicitor of Clavibacter michiganensis subspecies sepedonicus. Phytopathology 89(6 Suppl): S56

Winter, W.T. 2002: HR/MAS studies of cellulose particle surfaces. Abstracts of Papers American Chemical Society 223(1-2): CELL 44

Cardwell, E.M.; Glisson, S.; Gaugler, M.; Shum Siu, A.; Su, L.; Bumpous, J.M.; Hendler, F.J. 2000: HRAS1 mutations frequently occur in smokeless tobacco-induced oral cavity tumors but are rare in tumors occurring in cigarette smokers. Proceedings of the American Association for Cancer Research Annual Meeting 41: 294

Van Gils, C.H.; Conway, K.; Li, Y.; Taylor, J.A. 2002: HRAS1 variable number of tandem repeats polymorphism and risk of bladder cancer. International Journal of Cancer 100(4): 414-418

Hansell, D.M. 2001: HRCT of obliterative bronchiolitis and other small airways diseases. Seminars in Roentgenology 36(1): 51-65

Maher, V.M.; Li, Z.; Mcmanus, T.P.; Mccormick, J.J.; Lawrence, C.W.; Wang, X.D. 2003: HREV3 is essential for error-prone translesion synthesis past UV- or benzo pyrene diol epoxide -induced DNA lesions in human fibroblasts. Proceedings of the American Association for Cancer Research Annual Meeting 44: 379

Brooks, D.E.; Kallberg, M.E.; Komaromy, A.M.; Ollivier, F.J.; Dawson, W.W.; Sherwood, M.B.; Lambrou, G.N.; Percicot, C.L. 2001: HRF determined circulatory differences in the optic nerve head in laser induced glaucoma. IOVS Investigative Ophthalmology and Visual Science 42(4): S416

D.Croo, Herman 2004: HRH Princess Lilian a testimony. Acta Cardiologica 59(Suppl 1): 13-14

Cilli, E.M.; Nakaie, C.R.; Ribeiro, S.C.F.; Almeida, F.C.; Valente, A.P. 2002: HRMAS-NMR monitoring of the assembly of resin-bound aggregating sequences Effect of the peptide loading, amine group ionisation and the solvent system. Journal of Peptide Science 8(Suppl): S124

Sanda, M.G.; Dunn, R.; Wei, J.; Shah, N.L.; Lutz, M.; Mclaughlin, P.W.; Sandler, H.; Montie, J. 2002: HRQOL determinants of prostate cancer patient satisfaction after prostatectomy, external radiation or brachytherapy at referral and community practices. Journal of Urology 167(4 Suppl): 156-157

Mathias, S.D.; Colwell, H.; Miller, D.; Pasta, D.; Henning, J. 1999: HRQoL and QDIG of symptomatic non-erosive GERD patients treated with lansoprazole or ranitidine. Gastroenterology 116(4 Part 2): A78-A79

Schmand, M.; Casey, M.E.; Wienhard, K.; Eriksson, L.; Jones, W.F.; Lenox, M.; Young, J.W.; Baker, K.; Miller, S.D.; Reed, J.H.; Heiss, W.D.; Nutt, R. 1999: HRRT a new high resolution LSO-PET research tomograph. Journal of Nuclear Medicine 40(5 Suppl): 76P

Sandberg, K. 2002: HRT and SERMs: the good, the bad...and the lovely?. Trends in Endocrinology and Metabolism: Tem 13(8): 317-318

Kallberg, M.E.; Brooks, D.E.; Komaromy, A.M.; Dawson, W.W.; Sherwood, M.B.; Lambrou, G.N. 1999: HRT determined optic nerve head parameters in growing rhesus monkeys. IOVS Investigative Ophthalmology and Visual Science 40(4): S658

Wu, G.; Karbassi, J.A.; Mui, K.; Shiu, S.; Lai, D.; Hung, R. 2001: HRT documentation of Age related Macular Degeneration and Diabetic Retinopathy. IOVS Investigative Ophthalmology and Visual Science 42(4): S795

Lazarescu, A.D.; Lazarescu, D.; Blut, M.; Minne, H.W. 1999: HRT improves biological age and bone ultrasound measurements. Journal of Bone and Mineral Research 14(Suppl 1): S409

Genazzani, A.R.; Gambacciani, M. 2001: HRT in the third millennium. Maturitas 38(Suppl 1): S49-S55

Vrscaj, M.Ursic 2000: HRT in women with a history of breast cancer. European Journal of Cancer 36(Suppl 5): S86

Johnson, B.D.; Holubkov, R.; Merz, C.N. Bairey; Pepine, C.J.; Rogers, W.J.; Reichek, N.; Sharaf, B.L.; Kelsey, S.F.; Sopko, G.; Reis, S.E. 2002: HRT modulates brachial artery diameter and flow-mediated dilation The NHLBI-sponsored womens ischemia syndrome evaluation study. Journal of the American College of Cardiology 39(5 Suppl A): 220A

Mardin, C.Y.; Martus, P.; Hayler, J.; Juenemann, A. 2001: HRT morphometry of the optic disc Longterm reproducibility in normals and stable glaucoma patients. IOVS Investigative Ophthalmology and Visual Science 42(4): S16

Decensi, A.; Galli, A.; Veronesi, U. 2003: HRT opposed to low-dose tamoxifen Rationale and design. Senn, Hans-Jorg , Reprint Author, Morant, R Tumor prevention and genetics: 104-111

Gottlieb 1999: HRT raises risk of rare, treatable breast cancer. BMJ 318(7199): 1645B

Geiger, A.M.; Chen, W. 2002: HRT use after breast cancer Description of use and impact on survival. American Journal of Epidemiology 155(11 Suppl): S10

Giannikakis, S.I.; Landzberg, K.S.; Danias, J.; Gagliuso, D.J.; Podos, S.M. 2000: HRT vs stereoscopic disk photography in detecting progression in advanced glaucoma. IOVS Investigative Ophthalmology and Visual Science 41(4): S90

McLintock, C. 2002: HRT, VTE and surgery: what is best practice?. New Zealand Medical Journal 115(1157): U65

Villareal, R.C.; Leelawattana, R.; Klug, T.; Civitelli, R. 2001: HRT/ERT alters estrogen catabolism and catabolic products may predict response to therapy. Journal of Bone and Mineral Research 16(Suppl 1): S538

Wang, W.; Prince, C.Z.; Pollman, M.J. 2002: HRT1 signaling promotes vascular smooth muscle cell proliferation and survival Inhibition of p21WAF1/Kip1 expression and induction of Akt activity. Circulation 106(19): II143

Hermans, M.P.; Boland, B. 2000: HRTh improves insulin sensitivity and lipid profile in both non-diabetic and type 2 diabetes women. International Journal of Obesity 24(Suppl 1): S69

Sosnowski, M.; Korzeniowska, B.; Skrzypek Wanha, J.; Czyz, Z.; Boczkowska Gaik, E.; Macfarlane, P.W.; Tendera, M. 2002: HRV adjustment for age and mean RR interval disclose a different prognostic value of HRV measure in men and women with coronary heart disease. European Heart Journal 23(Abstract Suppl): 408

Virtanen, P.; Vasankari, T.; Vuorimaa, T.; Laukkanen, R. 2001: HRV plateau in exercise intensity determination in endurance athletes. Medicine and Science in Sports and Exercise 33(5 Suppl): S108

Shen, Che Kun James 2001: HS-40 enhancer-containing vector. Official Gazette of the United States Patent and Trademark Office Patents 1251(3)

Davis, B.H.; Chen, A. 1999: HSC collagen gene expression during fibrogenesis requires MEKK/SEK stimulated p32 binding end. Hepatology 30(4 Part 2): 513A

Bernstein, S.L.; Liu, A.M.; Somiari, R.I. 2000: HSC70 expression decreases during aging of the primate retina. IOVS Investigative Ophthalmology and Visual Science 41(4): S400

Su, C.Y.; Scott, B.T.; Belke, D.; Dillmann, W.; Lai, C.C. 2003: HSC70 suppresses the induction of HSP60 A preventive approach to atherosclerosis?. FASEB Journal 17(4-5): Abstract 809

Degenhardt, A.; Winterhalter, P. 2001: HSCCC A powerful tool for the preparative isolation of biologically-active compounds from nutritional beverages. Abstracts of Papers American Chemical Society 222(1-2): AGFD106

Simmons, R.M.; Satterfield, M.C.; Welsh, T.H.; Bazer, F.W.; Spencer, T.E. 2010: HSD11B1, HSD11B2, PTGS2, and NR3C1 expression in the peri-implantation ovine uterus: effects of pregnancy, progesterone, and interferon tau. Biology of Reproduction 82(1): 35-43

Bocchi, B.; Kenouch, S.; Lamarre Cliche, M.; Bonvalet, J.P.; Farman, N. 2002: HSD2 activity is reduced in aldosterone target cells of patients with essential hypertension. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 28A

Sarkar, G.; Fuchs, B.; Dion, N.; Bolander, M.E. 2003: HSEP1 is a tumor suppressor gene in osteogenic sarcoma. Calcified Tissue International 72(3): 257

Locke, M. 1999: HSF activation and HSP 72 accumulation in aged skeletal muscle. Medicine and Science in Sports and Exercise 31(5 Suppl): S162

Chang, J.; Wasser, J.S.; Knowlton, A.A. 1999: HSF activation and increased expression of HSP72 is mediated by stretch-activated channels in the isolated perfused rat heart. FASEB Journal 13(5 Part 2): A769

Yan, L.J.; Christians, E.; Sohal, R.; Benjamin, I.J. 2001: HSF1 deficiency increases oxidative damage of cardiac ANT1 and alters MPT pore opening in mice. Circulation 104(17): 2; 94

Diez Sampedro, A.; Hirayama, B.A.; Lai Bing, M.; Oswald, C.; Gorboulev, V.; Baumgarten, K.; Volk, C.; Ko 2003: HSGLT3 a human glucose sensor. FASEB Journal 17(4-5): Abstract 583

Sole, M.; Castillo, M.; Iglesias Felip, C.; Cuberes, T.; Esteve, R.; Maderuelo, F. 2002: HSIL overdiagnosis in primary screening and rescreening. Acta Cytologica 46(1 Suppl): 233

Mariani, M.; Souto, M.; Davila, J.; Azar, E. 2000: HSP 25/27, HSP 70 and hormonal receptor expression in rat oviduct during early pregnancy. Biocell 24(3): 296

De, A.K.; Kodys, K.; Yeh, B.; Miller Graziano, C. 1999: HSP 27 activated both TNFalpha and IL-10 production in human Mphi. Journal of Leukocyte Biology (Suppl ): 22

De, A.K.; Kodys, K.; Miller Graziano, C. 1999: HSP 27 signals Mvariant phi IL-10 vs IL-12 via differing pathways and with different potency for normals vs immunodepressed trauma patients. Cytokine 11(11): 952

Desouza, M.; Williams, C.; Albaugh, G.; Armour, R.; Reid, L.; Strande, L.; Hewitt, C.; Alexander, J. 2003: HSP 70 is cytoprotective against the pathologic changes induced by nicotine in vascular smooth muscle cells in vitro. Modern Pathology 16(1): 62A-63A

Park, K.C.; Kim, D.S.; Choi, H.O.; Chung, J.H.; Kim, H.J.; Choi, K.H.; Seo, J.S. 2000: HSP 70 prevents ultraviolet B-induced apoptosis of human melanoma cells. Journal of Investigative Dermatology 114(4): 866

Li, F.; Wang, Y.; Ruchalski, K.; Schwartz, J.H.; Borkan, S.C. 2001: HSP 72 inhibits apoptosis in ATP depleted renal epithelial cells. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 786A

Mao, H.; Li, F.; Wang, Y.; Schwartz, J.H.; Borkan, S.C. 2002: HSP 72 prevents detachment of ATP depleted renal epithelial cells. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 140A

Lucas, M.; Chant, I.; Morris, A.; Basu, S.; Rose, P.E. 1999: HSP 72 upregulates apoptosis in HUVECs by agents acting via membrane signalling pathways. British Journal of Haematology 105(Suppl 1): 40

Park, S.; Suetsugu, S.; Takenawa, T. 2003: HSP 90 regulates v-src tyrosine kinase-induced reorganization of actin cytoskeleton through conformational stabilization of N-WASP. Cell Structure and Function 28(4): 319

Aufricht, C. 2004: HSP: helper, suppressor, protector. Kidney International 65(2): 739-740

Robert, J.; Cohen, N. 2000: HSP a possible evolutionary bridge between innate and adaptive immunity. Developmental and Comparative Immunology 24(Suppl 1): S53-S54

Walters, T.J.; Mason, P.A.; Lehnert, H.M.; Mahajan, K.; Scholin, T.L.; Ryan, K.L. 1999: HSP expression in the CNS may be dissociated from whole-body thermotolerance. FASEB Journal 13(5 Part 2): A743

Vasilaki, A.; Jackson, M.J.; Mcardle, A. 2000: HSP production in skeletal muscle of young and old rats following exercise. Clinical Science 99(2): 22P

Van Why, S.; Thulin, G.; Mann, A.S.; Kashgarian, M.; Siegel, N.J. 2001: HSP-27 overexpression limits injury from ATP depletion in renal epithelia. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 185A

Ferris, S.; Van Why, S.K.; Ardito, T.; Siegel, N.J.; Kashgarian, M. 2000: HSP-27 prevents death of renal epithelia injured by limited energy depletion. Pediatric Research 47(4 Part 2): 446A

Plekhanov, A.Y.; Mokrushin, A.A.; Pavlinova, L.I.; Guzhova, I.V.; Margulis, B.A. 2004: HSP-70 and other polypeptides secreted by nerve cells in diverse functional states Changes in secretion and neurotropic effects. Journal of Neurochemistry 88(Suppl 1): 76

Brandhorst, D.; Kumarasamy, V.; Maataoui, A.; Brandhorst, H.; Bretzel, R.G. 2000: HSP-70 overexpression reduces necrosis triggered by inflammatory mediators but simultaneously increases caspase-3 like activities. Acta Diabetologica 37(3): 147

Fischer, H.; Huber, V.; Lub, H.; Neumann, J.; Schmitz, W.; Domschke, W.; Konturek, T.W. 1999: HSP-70, cyclooxygenases and no-synthases during gastric adaptation to aspirin in humans - Role of Helicobacter. Gastroenterology 116(4 Part 2): A222

Bidmon, B.; Herkner, K.; Aufricht, C. 1999: HSP-72 shifts in-vitro into the cytoskeletal fraction of rat renal cortex obtained after renal ischemia. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 629A

Willoughby, D.S.; Priest, J.W. 2001: HSP-72, ubiquitin, and myofibrillar protein in the spinal cord injured following 12-weeks of passive exercise. Medicine and Science in Sports and Exercise 33(5 Suppl): S30

Benndorf, R.; Gilmont, R.; Slawny, N.; Liu, C.; Welsh, M.J. 2000: HSP22, a new mammalian small heat shock protein, interacts with the phosphorylated form of HSP27. FASEB Journal 14(4): A50

Park, S.H.; Osawa, Y.; Lee, Y.S.; Tokino, T.; Takada, Y.; Hirama, T.; Hachiya, M.; Akashi, M. 2000: HSP25 regulates the expression of p21WAF1 through multiple mechanisms. Proceedings of the American Association for Cancer Research Annual Meeting 41: 588

Thompson, H.S.; Ring, J.E.; Scordilis, S.P. 2003: HSP25, HSC70 and HSP70 adaptations following uphill or downhill running in mice. FASEB Journal 17(4-5): Abstract 317

Stupka, N.; Phillips, S.; Yardley, N.; Tarnopolsky, M.A. 2000: HSP27 and HSP72 expression in skeletal muscle following repeated eccentric exercise in males and females. Medicine and Science in Sports and Exercise 32(5 Suppl): S246

Laudanski, K.; De, A.; Miller Graziano, C. 2002: HSP27 modulates TLR4 but not TLR2. Journal of Endotoxin Research 8(3): 172

Eaton, P.; Shattock, M.J. 2001: HSP27 multimeric size is regulated by S-thiolation independently of phosphorylation Studies in rat heart during ischemia/reperfusion and oxidant stress. Circulation 104(17): 2; 93

Wang, P.; Su, X.; Ibitayo, A.I.; Bitar, K.N. 1999: HSP27 phosphorylation regulates smooth muscle contraction through its interaction with tropomyosin. Gastroenterology 116(4 Part 2): A959

Thompkins, P.B.; Krzewski, K.; Griffiths, B.; Emery, P.; Lipinska, B.; Lindsey, N.J.; Ashraf, W. 2000: HSP40 and chronic autoimmune disease. Immunology 101(Suppl 1): 105

Wang, J.F.; Olson, M.E.; Wright, J.B.; Hart, D.A. 2001: HSP47 expression is up-regulated during skin wound healing in a porcine mode. Wound Repair and Regeneration 9(2): 150

Jabs, A.; Lentini, S.; Badimon, J.J.; Fuster, V.; Luederitz, B.; Bauriedel, G. 2001: HSP47 in early vascular remodeling. Journal of the American College of Cardiology 37(2 Suppl A): 288A

Matsuoka, Y.; Kubota, H.; Adachi, E.; Nagai, N.; Hosokawa, N.; Nagata, K. 2003: HSP47-knockout embryoid bodies are deficient in type IV collagen maturation and basement membrane formation. Cell Structure and Function 28(4): 308

Boilard, M.; Bailey, J.L.; Sirard, M.A.; Leclerc, P. 2003: HSP60 and GRP78 are localized on the surface of oviduct epithelial cells in the bovine and maintain sperm motility, viability, and acrosome integrity. Biology of Reproduction 68(Suppl 1): 172

Cohen, I.R.; Quintana, F.J.; Nussbaum, G.; Cohen, M.; Zanin Zhorov, A.; Lider, O. 2003: HSP60 and the regulation of inflammation Physiological and pathological. van Eden, W , Reprint Author Heat shock proteins and inflammation: 1-13

Schuchmann, M.; Hermann, F.; Herkel, J.; Van Der Zee, R.; Galle, P.R.; Lohse, A.W. 2002: HSP60 modulates hepatic response of the innate immune system. Hepatology 36(4 Part 2): 236A

Lee, G.; Kim, C.D.; Lee, H.S.; Lee, S.J.; Kim, K.H.; Jeen, Y.T.; Song, C.W.; Um, S.H.; Lee, S.W.; Choi, J.H.; Ryu, H.S.; Hyun, J.H. 1999: HSP60 protects cerulein-induced pancreatitis by attenuating cytokine response. Gastroenterology 116(4 Part 2): A1143

Soderstrom, K. 2003: HSP60-peptide interference with CD94/NKG2 receptors. van Eden, W , Reprint Author Heat shock proteins and inflammation: 257-272

Ribeiro, A.M.; Bocca, A.L.; Amaral, A.é C.; Souza, A.C.C.O.; Faccioli, L.úc.H.; Coelho-Castelo, A.A.M.; Figueiredo, F.ên.; Silva, C.él.L.; Felipe, M.S.S. 2010: HSP65 DNA as therapeutic strategy to treat experimental paracoccidioidomycosis. Vaccine 28(6): 1528-1534

Pshennikova, M.G.; Belkina, L.M.; Bakhtina, L.Y.; Baida, L.A.; Smirin, B.V.; Malyshev, I.Y. 2001: HSP70 and NO in rats with different resistance to myocardial infarction. Journal of Molecular and Cellular Cardiology 33(6): A97

Bhagat, L.; Agrawal, S.; Singh, V.P.; Song, A.M.; Van Acker, G.J.; Mykoniatis, A.; Steer, M.L.; Saluja, A.K. 2001: HSP70 antisense oligonucleotide administration prevents the thermal stress-induced expression of HSP70 in rat pancreas and abolishes the thermal stress-induced protection against caerulein-induced pancreatitis. Gastroenterology 120(5 Suppl 1): A 537

Chandrasekhar, S.; Schwarz, C.; Abcouwer, S.F. 1999: HSP70 expression and HSF1 activation following heat shock is inhibited in human breast cells deprived of the amino acid glutamine. FASEB Journal 13(5 Part 2): A742

Satyanarayana, T.; Gowda, S.; Mawassi, M.; Albiach Marti, M.R.; Dawson, W.O. 2000: HSP70 homolog and p61 in addition to the two coat protein genes of citrus tristeza closterovirus are required for efficient assembly of infectious virions. Phytopathology 90(6 Suppl): S69

Sato, K.; Matsuki, N. 1999: HSP70 protects pyramidal neurons in the hippocampus and may modulate region-dependent vulnerability. Society for Neuroscience Abstracts 25(1-2): 757

Cruz Rodriguez, L.A.; Chu, F.L.n E. 2001: HSP70 response in oyster Crassostrea virginica exposed to CD2+ and PAHs sorbed to artificial sediments. Journal of Shellfish Research 20(1): 554

Barnes, J.A.; Dix, D.J.; Collins, B.W.; Allen, J.W. 2000: HSP70 stimulates cell proliferation and is cytoprotective against heat and vincristine toxicity in MCF-7 cells. Proceedings of the American Association for Cancer Research Annual Meeting 41: 58

Capelli, E.; Campo, I.; Martinetti, M.; Salvaneschi, L.; Cuccia, M. 2002: HSP70-1 gene expression in human lymphocytes following extracorporeal fotochemotherapy Study of a model in vitro. Tissue Antigens 59(2 Suppl): 114

Perry, R.T.; Collins, J.S.; Harrell, L.E.; Go, R.C.P. 1999: HSP70-1 promoter polymorphisms in AD sibships-NIMH Genetics Initiative AD Study Group. American Journal of Human Genetics 65(4): A393

Bogunia Kubik, K.; Koscinska, K.; Suchnicki, K.; Lange, A. 2004: HSP70-hom single nucleotide polymorphisms and HLA-DRB1 affect the course of sarcoidosis. Genes and Immunity 5(Suppl 1): S24

Sheikh Hamad, D.; Chen, Y.R.; Tan, T.H.; Mazur, V.; Yang, Y. 1999: HSP70-mediated cross-talk between JNK1 and p38 kinase in osmotically stressed MDCK cells. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 58A

Kuhnen, S.; Trivella, Daniela B.B.; Claudia, M.; Da Silva, S.; Marques, Maria R.F. 2002: HSP70-stress response in brown mussel exposed to elevated temperature and copper. Marine Environmental Research 54(3-5): 837

Nelson, M.J.; Bois, C.; Brown, M.; Willoughby, D.S. 2001: HSP72 expression following an acute bout of high intensity weight training. Medicine and Science in Sports and Exercise 33(5 Suppl): S67

Febbraio, M.A.; Steensberg, A.; Osada, T.; Walsh, R.C.; Saltin, B.; Pedersen, B.K.arlund 2001: HSP72 expression is influenced by glycogen availability in contracting human skeletal muscle. Medicine and Science in Sports and Exercise 33(5 Suppl): S307

Wang, Y.H.; Mao, H.P.; Borkan, S.C.; Sharifi, S. 2003: HSP72 interacts with paxillin in renal epithelial cells subjected to chemical ischemia. Modern Pathology 16(1): 269A

Hamilton, M.G.; Oks, M. 2003: HSP7O in the gill and mantle of the oyster, Crassostrea virginica. Abstracts of Papers American Chemical Society 226(1-2): BIOL 222

Haendeler, J.; Rahman, S. 2001: HSP90 and Akt are associated with TERT and necessary for the anti-apoptotic function of TERT. Circulation 104(17): 2; 20

Gius, D.; Neckers, L.; Bradbury, M.; Harris, J. 2003: HSP90 inhibition with geldanamycin/17-AAG increases cytotoxicity, radiosensitization in cervical tumor cells Implications for the radiation oncology. Blood 102(11): 212b

Choi, Y.; Yim, S.; Choi, S.M.I.; Kim, H.H.; Kwon, H.J.; Lee, E.; Park, H. 2002: HSP90 inhibitor, radicicol reduces hypoxia-inducible gene expression. Proceedings of the American Association for Cancer Research Annual Meeting 43: 1025

Liu, M.H.; Bernstein, S.L. 1999: HSP90 is a carrier of TrkB neurotrophin receptors and signal transduction in optic nerve transport. IOVS Investigative Ophthalmology and Visual Science 40(4): S11

Billecke, S.S.; Bender, A.T.; Kanelakis, K.C.; Lowe, E.R.; Murphy, P.J.M.; Kamada, Y.; Pratt, W.B.; Osawa, Y. 2002: HSP90 is required for heme binding and activation of heme-deficient NO-synthase Geldanamycin-mediated oxidant generation from nNOS is independent of HSP90. Nitric Oxide 6(4): 362

Inoue, T.; Fukunaga, Y.; Tabuse, Y.; Miwa, J.; Yamaguchi, Y. 2001: HSP90 mRNA in the nematode caenorhabditis elegans under heat stress. Cell Structure and Function 26(5): 504

Peng, X.; Guo, X.; Abdul, K.M.; Grammatikakis, N.; Bharti, A.; Calderwood, S.; Sawyer, D.B. 2003: HSP90 regulates ErbB2 stability and expression in cardiac myocytes. Circulation 108(17): IV204

Tysnes, B.B.; Hoover, F.; Afione, A.; Kotin, R.; Bjerkvig, R.; Lonning, P.E.; Thorsen, F. 2002: HSPG quantity associates with AAV2 transduction efficiency in glioma and breast cancer cells. International Journal of Cancer Suppl (13): 318-319

Goulhen, F.; Dedieu, L.; Pages, J.M.; Bolla, J.M. 2003: HSPs and MOMP upregulation as a component of the Campylobacter jejuni thermo tolerance. IJMM International Journal of Medical Microbiology 293(Suppl 35): 57-58

Kotula, L.; Xu, J.; Ziemnicka Kotula, L.; Merz, G.S. 2000: HSSH3BP1 regulates macropinocytosis in NIH 3T3 cells. Cell Biology International 24(12): 980

Cantin, E.M.; Lundberg, P.; Han, X.; Welander, P.; Wu, M. 2000: HSV DNA is highly immunostimulatory in vitro and in vivo A role in herpes stromal keratitis?. IOVS Investigative Ophthalmology and Visual Science 41(4): S56

Maguire Zeiss, K.A.; Bowers, W.J.; Federoff, H.J. 2002: HSV amplicon vectors in neuronal apoptosis studies. LeBlanc, Andrea C Neuromethods Apoptosis techniques and protocols 61-82

Field, H.J. 1999: HSV as a paradigm for antiviral drug action. Journal of Antimicrobial ChemoTherapy 44(Suppl A): 8

Leibole, M.A.; Herndon, J.M.; Ferguson, T.A. 2001: HSV infection upregulates Fas Ligand expression. IOVS Investigative Ophthalmology and Visual Science 42(4): S42

Simoneau, B.; Liuzzi, M.; Mentrup, A. 2001: HSV primase inhibitors. Official Gazette of the United States Patent and Trademark Office Patents 1252(4)

Johnston, D.C.; York, I.A. 1999: HSV proteins for inhibiting recognition by cytotoxic lymphocytes. Official Gazette of the United States Patent and Trademark Office Patents 1218(2): 1172

Brandt, C.R.; Spencer, B. 2000: HSV vector-mediated delivery of FGF2 protects photoreceptors from light-mediated degeneration. IOVS Investigative Ophthalmology and Visual Science 41(4): S396

Federoff, H.J.; Maguire Zeiss, K.; Wuertzler, C.; Lim, K.; Lim, S.; Bowers, W. 2003: HSV vector-mediated gene delivery. Journal of Neurovirology 9(Suppl 3): 51

Breakefield, X.O.; Grandi, P.; Sena Esteves, M.; Shah, K.; Kumar, S.; Krasnykh, V.; Curiel, D.; Tung, C.; Weissleder, R. 2003: HSV vectors for targeting, regulation and imaging of tumor death. Cancer Gene Therapy 10(Suppl 1): S16

Uuskula, A.; Kibur, M.; Robinson, N.J.; Tamm, A.; Hsv Seroepidemiology Multi Centre Study Group 2001: HSV-1 and HSV-2 seroprevalence study in Estonia. International Journal of STD and AIDS 12(Suppl 2): 152

Leib, D.A.; Margolis, T.P.; Summers, B.C. 2001: HSV-1 corneal infection results in periocular disease by zosteriform spread in humans and mice. IOVS Investigative Ophthalmology and Visual Science 42(4): S42

Kwon, B.; La, S.; Song, H.; Woo, J.; Lim, H.; Lee, H.W.; Kwon, B.S. 2001: HSV-1 gD is a potent antagonist for T-cell activation. FASEB Journal 15(5): A1011

Scheglovitov, O.N.; Romanov, Y.A.; Macsianina, E.V.; Kabaeva, N.V. 2001: HSV-1 infected human endothelial cells induce in PBMC production of cytokines, which modulate HSV-I replication in native endothelial cells. Journal of Interferon and Cytokine Research 24(Suppl 1): S 135-S 136

Zheng, X.; Marquart, M.E.; Loustch, J.M.; O'callaghan, R.J.; Kaufman, H.E.; Hill, J.M. 1999: HSV-1 migration in latent and naive rabbits following penetrating keratoplasty. IOVS Investigative Ophthalmology and Visual Science 40(4): S762

Branston, R.; Perez, C.P.; Palmer, J.A.; Robinson, M.J.; Holmes, F.; Hunt, S.P.; Latchman, D.S.; Coffin, R.S. 2000: HSV-1 viral vectors for the peripheral nervous system Delivery of potentially regenerative molecules. European Journal of Neuroscience 12(Suppl 11): 307

Aurelian, L.; Smith, C.C. 2001: HSV-2 transformation A multistep process mediated by distinct mutagenic DNA sequences and viral genes includes activation of the Ras/MEK/MAPK mitogenic pathway. Rosenthal, Leonard J Monographs in Virology Mechanisms of DNA tumor virus transformation 64-87

Pulkkanen, K.; Parkkinen, J.; Laukkanen, J.; Kettunen, M.; Tyynela, K.; Kauppinen, R.; Ala Opas, M.; Yla Herttuala, S. 2001: HSV-TK gene therapy of human renal cell carcinoma in nude mice. Scandinavian Journal of Urology and Nephrology 35(Suppl 208): 29-30

Majumdar, A.S.; Hughes, D.E.; Lichtsteiner, S.; Morin, G.; Chiu, C.P.; Lebkowski, J.S.; Vasserot, A. 2000: HSV-TK suicide gene therapy using human telomerase reverse transcriptase promoter. Proceedings of the American Association for Cancer Research Annual Meeting 41: 379

Boucher, P.D.; Shewach, D.S. 1999: HSV-TK/GCV bystander killing can be achieved in SW620 cocultures containing as few as 1 percent HSV-TK-expressing cells by addition of hydroxyurea. Proceedings of the American Association for Cancer Research Annual Meeting 40: 87

Wolf, D.H.; Russell, D.S. 1999: HSV-mediated neuronal expression of a truncated Insulin Receptor Substrate-2. Society for Neuroscience Abstracts 25(1-2): 1529

Canfield, S.E.; Hassen, W.A.; Yan, Y.; Hall, S.J. 2001: HSV-tk and IL-12 gene therapy orchestrate a bystander effect through Fas and FasL interactions in experimental prostate cancer. Journal of Urology 165(5 Suppl): 142

Gerolami, R.; Cardoso, J.; Lewin, M.P.; Bralet, M.P.; Cunha, A. Sa.; Bregerie, O.; Clement, O.; Brechot, C.; Tran, P.L. 1999: HSV-tk gene therapy in a rat model of chemically-induced hepatocellular carcinoma by intra-hepatic artery and intra-tumor routes. Proceedings of the American Association for Cancer Research Annual Meeting 40: 593

Butler, B. 2000: HSV-tk-GCV gene therapy and radiation From the lab to the clinic A model for a gene therapy clinical trial. Radiotherapy and Oncology 56(Suppl 1): S51

Guest, J.D.; Bakowska, J.; Breakefield, X.O.; Huang, T.; Sonntag, V.K.H.; Jia, W. 1999: HSV/AAV hybrid amplicon vector surpasses recombinant HSV ICP 6 in gene delivery from peripheral nerve to spinal motor neurons. Society for Neuroscience Abstracts 25(1-2): 1839

Breakefield, X.O.; Jacoby, D.R.; Smith, F.I. 1999: HSV/AAV hybrid amplicon vectors. Official Gazette of the United States Patent and Trademark Office Patents 1227(2)

Chiocca, E.A.; Saeki, Y.; Wade Martins, R.; Aghi, M.; Tyminski, E.; Wakimoto, H.; Fulci, G.; Terada, K.; Abe, T.; Basilion, J.; Smith, E.; Asadi, K. 2002: HSV1 A virus for tumor lysis and a vector for functional genomics. Journal of Neurovirology 8(Suppl 1): 37

Ye, G.; Liu, W.; Zhang, R. 2003: HSVTK-mediated local and distant antitumor bystander effect on T739 bladder tumor in T739 mice. Journal of Urology 169(4 Suppl): 193

Meersma, Gert Jan; De Jong, Steven; Hospers, Geke; Helder, Marco; Van Der Zee, Ate 2003: HSVtk mediated gene therapy using a semliki forest virus based non-viral vector. Proceedings of the American Association for Cancer Research Annual Meeting 44: 1301

Aoyagi, S.; Zheng, C.; Sif, S.; Kingston, R.E.; Hayes, J.J. 2001: HSWI/SNF remodeling in the absence of nucleosome sliding. Biochemistry and Cell Biology 79(3): 371

Borg, J-P. 2004: hScrib: a potential novel tumor suppressor. Pathologie-Biologie 52(6): 328-331

Day, N.S.; Melman, A.; Smith, W.L.; Santizo, C.; Sato, Y.; Zhao, W.; Day, M.; Chen, F.; Valcic, M.; Rehman, J.; Bakal, R.; Christ, G.J. 1999: HSlo transcript is locally restricted after a single intracavernous injection of naked hSlo/pcDNA. FASEB Journal 13(4 Part 1): A356

Ulgiati, S. 2004: HT Odum and EC Odum, the prosperous way down. Ecological Modelling 178(1-2): 247-250

Steimer, W.; Popp, J.; Zoepf, K.; Von Amelunxen, S.; Messner, B.; Pfeiffer, H.; Kissling, W.; Leucht, S. 2004: HT-2A -1438 G/A promoter polymorphism Fast real time PCR method and lack of association with response or side effects in amitriptyline treated inpatients. Clinical Chemistry 50(6, Suppl S, Part 2): A120

Edwards, B.S.; Kucuck, F.W.; Prossnitz, E.R.; Sklar, L.A.; Okun, A.; Ransom, J.T. 2000: HT-PS and plug flow cytometry for multi-well plate drug screening. Cytometry Suppl (10): 25

Ko, Kwang Ho 1999: HTA, against hamster tracheal mucin. Hybridoma 18(5): 469

Parajua Pozo, J.L.; Lopez Pousa, S.; Turon Estrada, A.; Urcola Pinol, M.; Garcia Rafanell, J. 2002: HTB levels in cerebrospinal fluid. Journal of the Neurological Sciences (203-204): 319

Liu, J.; Thompson, J.A.; Zhou, C.; Wu, H.; Xu, X.; Hahn, W.C.; Malpica, A.; Deavers, M.T.; Gershenson, D.M.; Silva, E.G. 2001: HTERT activity and expression pattern in normal and neoplastic ovarian cell lines and tissues. Proceedings of the American Association for Cancer Research Annual Meeting 42: 404

D.K.k, J.; Verhaegh, G.; Roelofs, R.; Hessels, D.; Kiemeney, B.; Aalders, T.; Swinkels, D.; Schalken, J. 2002: HTERT and DD3/PCA3 gene expression in prostatic tissues Differentiation between normal prostate, benign prostate hyperplasia and prostate tumours. European Urology Suppls 1(1): 7

Sharma, G.G.; Gupta, A.; Young, C.S.; Dhar, S.; Gandhi, V.; Shay, J.W.; Iliakis, G.; Pandita, T.K. 2002: HTERT associating with telomeres reduces spontaneous chromosome damage and enhances DNA repair. Proceedings of the American Association for Cancer Research Annual Meeting 43: 301

Kirkpatrick, K.L.; Ongunkolade, W.; Elkak, A.; Ghilchik, M.; Bustin, S.; Jenkins, P.; Mokbel, K. 2001: HTERT expression in human breast cancer and adjacent non-cancerous breast tissue. Breast Cancer Research and Treatment 69(3): 274

Kirkpatrick, K.; Ongunkulade, W.; Elkak, A.; Ghilchik, M.; Bustin, S.; Jenkins, P.; Mokbel, K. 2002: HTERT expression in human breast cancer and adjacent non-cancerous breast tissue Correlation with tumour stage. European Journal of Cancer 38(Suppl 3): S163-S164

Wang, L.; Soria, J.-C.; Kemp, B.L.; Liu, D.D.; Mao, L.; Khuri, F.R. 2002: HTERT expression is a prognostic factor of survival in patients with stage i non-small cell lung cancer. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 8(9): 2883-2889

Kirkpatrick, K.L.; Carpenter, R.; Ongunkolade, W.; Laban, C.; Elkak, A.; Ghilchick, M.; Bustin, S.; Jenkins, P.; Mokbel, K. 2001: HTERT expression is significantly higher in breast cancer tissue than in adjacent non-cancerous tissue. British Journal of Cancer 85(Suppl 1): 85

Drummond, M.; Hoare, S.; Alcorn, M.; Graham, S.; Keith, W.; Holyoake, T. 2002: HTERT gene expression is increased by alternative splicing on mRNA during the course of CML, and telomere loss at diagnosis is associated with early progression. Experimental Hematology (Charlottesville) 30(6 Suppl 1): 115

Drummond, M.W.; Hoare, S.; Alcorn, M.J.; Monaghan, A.; Graham, S.; Keith, W.N.; Holyoake, T.L. 2002: HTERT gene expression is regulated by alternative splicing of mRNA during the course of CML, and telomere loss at diagnosis is associated with early progression. British Journal of Cancer 86(Suppl 1): S18-S19

Takuma, Y.; Nouso, K.; Kobayashi, Y.; Uemura, M.; Yumoto, E.; Nakamura, S.; Tanaka, H.; Matsumoto, E.; Sato, S.; Fujikawa, T.; Suzuki, M.; Toshikuni, N.; Shiratori, Y. 2002: HTERT gene was amplified especially in poorly differentiated hepatocellular carcinoma. Hepatology 36(4 Part 2): 392A

Stampfer, M.R.; Garbe, J.; Levine, G.; Lichtsteiner, S.; Vasserot, A.; Yaswen, P. 2000: HTERT induces TGFbeta growth resistance in human mammary epithelial cells. Proceedings of the American Association for Cancer Research Annual Meeting 41: 225

Hiendlmeyer, E.; Wassermann, S.; Haynl, A.; Brabletz, T.; Kirchner, T.; Jung, A. 2002: HTERT is a beta-catenin target gene in colorectal cancer. Pathology Research and Practice 198(3): 231

Hiendlmeyer, E.; Wassermann, S.; Herbst, H.; Brabletz, T.; Haynl, A.; Kirchner, T.; Jung, A. 2002: HTERT is a beta-catenin target gene in human colorectal cancer. Proceedings of the American Association for Cancer Research Annual Meeting 43: 667-668

Rohde, V.; Bund, T.; Zwergel, T.; Wullich, B. 2000: HTERT mRNA expression is not indicative for telomerase activity in human renal tissue. Journal of Urology 163(4 Suppl): 114

Goodison, S.; Ma, H.; Kleeman, J.; Urquidi, V. 2002: HTERT promoter regulation during differentiation of human muscle cell lineages. Proceedings of the American Association for Cancer Research Annual Meeting 43: 305

Wang, Z.; Powell, S.; Cardoza, L.; Lemos, B.; Chiu, C.P.; Lebkowski, J.; Irving, J.; Majumdar, A. 2002: HTERT promoter-driven conditionally replicative adenovirus mediated gene therapy induces efficacious tumor regression in vivo. Proceedings of the American Association for Cancer Research Annual Meeting 43: 83-84

Zihel, T.T.; Huge, A.; Kreis, M.E.; Becker, H.D.; Jehle, E.C. 1999: HTF 919, a new 5-HT4 receptor agonist, increases postoperative gastric and small intestinal motility in rats. Gastroenterology 116(4 Part 2): A1108

Prather, C.M.; Camilleri, M.; Mckinzie, S.; Thomforde, G.; Zinsmeister, A.R. 1999: HTF919, a partial 5HT4 agonist, accelerates small bowel transit in patients with constipation-predominant irritable bowel syndrome. Gastroenterology 116(4 Part 2): A1066-A1067

Loganzo, F.; Discafani, C.; Annable, T.; Beyer, C.; Musto, S.; Hardy, C.; Hernandez, R.; Baxter, M.; Ayral Kaloustian, S.; Zask, A.; Singanallore, T.; Khafizova, G.; Asselin, A.; Poruchynsky, M.S.; Fojo, T.; Nieman, J.; Andersen, R.J.; Greenberger, L.M. 2002: HTI-286, a synthetic analog of the anti-microtubule tripeptide hemiasterlin, potently inhibits growth of cultured tumor cells, overcomes resistance to paclitaxel mediated by various mechanisms, and demonstrates intravenous and oral in vivo efficacy. Proceedings of the American Association for Cancer Research Annual Meeting 43: 265

Newman, V.; Gonzalez, R.; Matthay, M.; Dobbs, L. 1999: HTI56, an integral apical membrane protein of the human alveolar type i cell, is a biochemical marker of acute lung injury. Chest 116(1 Suppl): 35s-36s

Bennett, B.D.; Matthews, W. 1999: HTK ligand. Official Gazette of the United States Patent and Trademark Office Patents 1218(4): 3160

He, G.W.; Yang, Q.; Yim, A.P.C.; Zhang, R.Z. 2003: HTK solution maximally preserves the EDHF-related endothelial function during heart and lung preservation comparison with University of Wisconsin and Euro-Collins Solutions. FASEB Journal 17(4-5): Abstract 149

Dow, B.C.; Munro, H.; Jarvis, L.; Jordan, A.; Hambley, H.; Rawlinson, S.; Lumley, S.; Gillon, J.; Galea, G.; Franklin, I.M. 2003: HTLV 1/2 in blood donors in Scotland The effect of leucocyte depletion of blood components and the value of donation archive samples. British Journal of Haematology 121(Suppl 1): 77-78

Payne, L.J.; Tosswill, J.H.; Taylor, G.P.; Simms, I. 2003: HTLV I and II infections in England and Wales 1988-2001. AIDS Research and Human Retroviruses 19(Suppl): S-35

Cabral, M.B.; Bouzas, B.; Cabello, A.; Samudio, M.; Leguizamon, M.; Oddone, R.; Pozzoli, L.; Andres, C.; Maciel, J. 2001: HTLV I/II retroviruses and parasitics diseases in Paraguay. Clinical Chemistry 47(S6): A95

Gurtsevitch, V.; De The, Guy; Hayami, M. 2001: HTLV among mongoloid population of Far Eastern and southern regions Siberia Prevalence, peculiaritis of infection pattern and possible origin. AIDS Research and Human Retroviruses 17(Suppl 1): S 37

Franchini, G. 2001: HTLV and immortalization/transformation Current concepts and clinical relevance. AIDS Research and Human Retroviruses 17(Suppl 1): S 5

Bittencourt, A.L.; Bastos, P.P.; Galvao Castro, B.; Santos, M.; Valadao, E.; Dourado, I. 1999: HTLV in infection among pregnant women in Salvador-Bahia. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 20(4): A55

Dougan, S.; Payne, L.J.; Tosswill, J.H. 2003: HTLV infection in England and Wales in 2002 Preliminary results from an enhanced national surveillance system. AIDS Research and Human Retroviruses 19(Suppl): S-33

Proietti, F.; Catalan Soares, B.; Proietti, A.B.; Caiaffa, W.T.; Giph Htlv Research Group 2003: HTLV infection in public Brazilian blood centers and intravenous drug users Considerations about prevention. AIDS Research and Human Retroviruses 19(Suppl): S-34

Miley, W.J.; Lifson, J.; Biggar, R.J.; Jacobson, S.; Goedert, J.J.; Whitby, D.; Hisada, M. 2001: HTLV provirus load in HTLV/HIV coinfected subjects is not significantly higher than in HTLV singly infected subjects. AIDS Research and Human Retroviruses 17(Suppl 1): S 39

Koch, M.C.; Rodrigues, E.; Ribeiro, G.; Pereira, L.; Araujo, F.; Aranda, D.; Cunha Ribeiro, L.M. 2000: HTLV screening A new approach?. Vox Sanguinis 78(Suppl 1): P411

Lin, H.; Matullo, C.M.; Swaims, A.; Rabson, A.B. 2003: HTLV-1 LTR-luciferase reporter cells for study of HTLV-1 infection and activation. AIDS Research and Human Retroviruses 19(Suppl): S-58

Fujii, M.; Higuchi, M.; Endo, K.; Takahashi, T.; Ohhashi, M.; Tezuka, T.; Shinohara, H.; Hirata, A.; Mori, N. 2002: HTLV-1: multistep leukemogenesis of adult T-cell leukemia. Uirusu 52(1): 103-108

Nicot, C.; Dundr, M.; Johnson, J.M.; Fukumoto, R.; Misteli, T.; Franchini, G. 2003: HTLV-1 P30II retains the Tax/Rex mRNA in the nucleus and suppresses replication of both HTLV-1 and -2. AIDS Research and Human Retroviruses 19(Suppl): S-20

Haoudi, A.; Daniels, R.; Semmes, J. 2003: HTLV-1 Tax oncoprotein functionally targets a subnuclear site involved in cellular DNA damage-response. AIDS Research and Human Retroviruses 19(Suppl): S-72

Tripp, A.C.; Worley, M.; Montalbano, J.; Feuer, G. 2003: HTLV-1 Tax sensitizes T-lymphoid cells to apoptosis and inhibits hematopoiesis in vitro. AIDS Research and Human Retroviruses 19(Suppl): S-61

Burton, M.; Upadhyaya, C.D.; Hope, T.J.; Semmes, O.J. 1999: HTLV-1 Tax shuttles between nuclear and cytoplasmic targets. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 20(4): A12

Konesky, K.L.; Nyborg, J.K.; Laybourn, P.J. 2003: HTLV-1 Tax transactivation on chromatin containing histone H1. AIDS Research and Human Retroviruses 19(Suppl): S-73